rfhg_82619.1

Basic information about the TSS

---

TSS ID: rfhg_82619.1 TSS ID(Version3): hg_73586.1 hg_73587.1 Species: human Chr: chr6		Start: 41941705 End: 41941822 Strand: -
Source datasets	FANTOM5|EPD|PRJDB5282|PRJNA548673|PRJNA597322|PRJNA615891 |PRJNA401781|PRJNA4843412|DRA013844
Protocol	CAGE|TSS_database|C1CAGE|ReCappable-seq|STRIPE-seq|TIF-seq2 |NETCAGE|SLIC_CAGE
TSS cluster detected*	11

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D3842083,EH38E2467297)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000372991.9:0 ENST00000414200.6:0 ENST00000510058.1:0 BC011616:0 M92287:0 M90814:0 AK315421:0 AK299187:0 GeneID: 896 HGNC/MGI_ID: HGNC:1585 UniProt_ID: B4DRB9 P30281 Nearer transcript ids and distances: LF212989:11 MA448566:11 CR542246:56 DQ891748:56 KJ890843:56 DQ895130:56 AB385206:56 ENST00000372987.8:186 AK055519:299 view more...

Gene_name: cyclin D3 Gene_symbol: CCND3 Gene_synonyms: Gene_source: HGNC:1585

TATA-Box annotation

---

Distance to TSS:	85
Nearest PromoterID:	NM_001760
Entrez ID:	896
Nearest Unigene:	Hs.534307
Nearest Refseq:	NM_001760
Nearest Ensembl:	ENSG00000112576
Gene Name:	cyclin D3
Gene Alias:	-
Gene Type:	protein-coding
CpG%:	0.205128
GC%:	0.855932
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@CCND3 p2@CCND3 p3@CCND3 p4@CCND3 p5@CCND3 p6@CCND3 p7@CCND3 p8@CCND3
Sample		p1@CCND3	p2@CCND3	p3@CCND3	p4@CCND3	p5@CCND3	p6@CCND3	p7@CCND3	p8@CCND3
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	15.00	3.31	4.48	10.32	0.19	0.19	0.39	0.00
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	19.62	3.84	4.86	8.09	0.20	0.00	0.40	0.00
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	12.54	3.67	6.17	9.45	0.19	0.00	0.58	0.00
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	14.76	4.57	3.33	11.64	1.04	0.00	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	17.77	4.05	3.60	8.32	0.22	0.00	0.45	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	15.70	5.23	1.94	9.30	0.19	0.00	0.19	0.19
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	20.26	8.06	5.45	14.82	0.22	0.00	0.44	0.00
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	17.20	10.66	4.84	9.69	0.97	0.00	0.73	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	21.16	10.69	8.55	16.46	0.43	0.00	0.21	0.43
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	15.07	11.59	4.06	16.23	0.00	0.00	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	20.62	10.91	3.64	10.51	0.40	0.00	0.40	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	12.60	11.79	4.88	16.67	0.00	0.00	0.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	1.29	2.26	1.29	0.97	0.16	0.00	0.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	1.95	3.91	1.50	0.45	0.15	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	1.76	3.95	1.32	0.88	0.22	0.22	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	2.26	3.52	0.75	0.50	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	0.87	3.28	0.66	0.44	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	2.11	4.64	1.27	1.27	0.00	0.00	0.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	3.73	2.13	0.00	0.53	0.00	0.00	0.53	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	2.26	3.01	0.75	1.20	0.15	0.00	0.15	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	2.00	3.61	1.34	0.67	0.00	0.00	0.27	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	2.59	2.24	1.38	1.04	0.17	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	3.23	3.62	0.52	0.78	0.00	0.00	0.13	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	2.18	3.40	0.73	1.21	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	3.87	4.64	1.03	1.55	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	2.22	2.53	1.58	0.32	0.32	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	3.30	4.95	1.10	0.55	0.55	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	5.19	3.30	2.83	2.12	0.24	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	2.75	2.75	1.62	0.65	0.16	0.16	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	2.90	2.90	1.45	0.36	0.00	0.18	0.18	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	4.19	1.47	1.47	0.42	0.42	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	2.54	2.34	0.59	0.78	0.20	0.20	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	4.22	2.95	1.27	0.63	0.00	0.00	0.21	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	1.81	2.31	0.99	0.66	0.16	0.00	0.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	4.11	2.06	1.31	0.19	0.00	0.00	0.75	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	5.37	2.49	1.92	1.92	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	3.27	2.04	0.82	0.20	0.41	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	2.42	2.22	1.01	1.41	0.40	0.40	0.40	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	6.21	1.89	1.35	1.35	0.00	0.00	0.54	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	2.64	2.40	1.44	1.68	0.24	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	4.23	1.41	2.35	1.41	0.24	0.00	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	2.05	2.05	2.05	1.32	0.00	0.15	0.15	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	5.06	2.53	2.32	1.48	0.00	0.00	0.63	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	5.77	1.57	2.97	1.57	0.35	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	5.22	1.41	2.81	1.81	0.40	0.00	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	6.75	1.86	2.09	2.33	0.47	0.00	0.23	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	4.08	2.40	1.20	1.20	0.00	0.00	0.48	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	6.26	2.68	2.98	0.60	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	7.90	3.11	2.63	3.83	0.24	0.00	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	6.27	2.43	1.82	1.62	0.61	0.20	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	6.56	1.23	3.69	1.64	0.20	0.00	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	6.00	4.23	3.11	3.11	0.22	0.00	0.44	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	8.52	1.77	3.90	2.48	1.42	0.00	0.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	4.97	2.32	2.98	2.65	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	1.68	1.68	0.00	0.00	0.84	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	4.13	1.38	1.84	0.46	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	3.24	1.30	5.19	1.62	0.32	0.00	0.65	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	4.82	2.57	2.57	3.21	0.64	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	1.89	1.57	2.51	1.26	1.26	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	4.23	0.00	3.53	7.05	0.71	0.00	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	5.05	1.68	1.68	3.36	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	0.80	1.59	0.80	0.80	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	1.36	2.04	1.70	1.70	0.00	0.00	0.68	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	2.27	2.60	2.92	3.57	0.32	0.00	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	3.19	2.84	2.84	4.26	0.00	0.00	0.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	10.24	0.00	4.39	3.41	0.49	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	6.45	0.99	4.46	0.99	0.00	0.00	0.50	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	8.91	0.94	4.69	3.28	0.47	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	3.31	0.66	3.64	0.33	0.33	0.00	0.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	4.02	2.78	2.78	3.09	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	4.59	2.14	3.06	1.22	0.00	0.00	0.00	0.00
Adipocyte - breast, donor1	11376-118A8	13.62	14.25	5.07	4.43	0.79	0.32	0.16	0.16
Adipocyte - breast, donor2	11327-117E4	17.97	12.03	6.10	3.37	0.32	0.16	1.28	0.00
Adipocyte - omental, donor1	11473-119C6	11.20	8.40	2.67	2.93	0.25	0.00	0.13	0.25
Adipocyte - omental, donor2	11474-119C7	20.93	20.18	2.24	5.23	2.24	0.00	1.49	0.00
Adipocyte - omental, donor3	11475-119C8	7.70	5.69	2.68	3.01	0.33	0.00	0.67	0.00
Adipocyte - perirenal, donor1	11476-119C9	10.85	15.31	5.10	6.38	0.64	0.00	0.64	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	15.39	1.10	7.70	3.30	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	21.23	6.77	9.03	4.52	0.45	0.00	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	43.97	4.00	11.12	9.04	0.52	0.00	0.70	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	38.72	4.11	13.69	4.89	0.20	0.00	0.98	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	12.10	2.83	4.63	4.63	0.51	0.00	0.26	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	21.74	3.62	8.92	5.58	1.12	0.00	0.00	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	25.86	4.11	4.70	3.53	0.00	0.00	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	69.66	1.21	23.08	12.23	0.64	0.00	0.64	0.00
Adipocyte differentiation, day08, donor2	13023-139D8	25.82	1.94	4.52	3.23	0.00	0.00	0.00	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	23.46	2.13	8.00	2.67	0.00	0.00	0.53	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	30.60	1.11	5.01	7.79	0.00	0.00	1.11	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	43.25	0.42	11.64	9.98	0.42	0.00	0.42	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	37.42	1.51	6.28	6.03	0.75	0.00	1.00	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	35.67	1.64	7.53	7.85	0.98	0.00	0.98	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	32.58	0.00	4.87	7.61	0.61	0.00	0.30	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	49.28	13.04	15.03	13.70	1.77	0.22	0.44	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	53.07	19.36	15.78	17.93	0.72	0.00	1.08	0.36
Alveolar Epithelial Cells, donor3	11671-122G6	7.19	34.74	4.79	1.20	2.40	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	113.88	17.27	18.71	17.81	1.62	0.36	0.54	0.18
Amniotic Epithelial Cells, donor2	11613-122A2	120.49	48.53	16.73	33.47	3.35	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	99.23	21.16	21.57	21.78	2.47	0.21	1.03	0.21
Anulus Pulposus Cell, donor1	11248-116E6	8.12	29.41	2.75	1.49	1.37	0.80	0.11	0.69
Anulus Pulposus Cell, donor2	11463-119B5	8.82	28.41	1.47	3.43	1.22	0.49	0.00	0.98
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	9.88	4.04	1.35	1.80	0.90	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	7.38	2.17	3.04	1.74	1.74	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	14.98	2.14	0.00	2.14	6.42	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	14.05	3.29	1.79	4.18	1.49	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	13.91	1.26	3.79	3.79	3.79	0.00	1.26	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	9.90	3.30	2.64	4.62	1.32	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	9.42	3.25	2.60	4.87	0.65	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	10.19	5.83	3.88	2.43	1.94	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	8.91	2.97	4.16	1.19	1.19	0.00	1.19	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	9.79	3.77	2.26	2.64	1.51	0.00	0.38	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	9.43	4.35	2.18	5.81	2.18	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	8.78	2.51	1.25	3.76	3.76	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	12.03	2.47	4.28	1.65	1.65	0.33	0.16	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	13.65	2.73	1.36	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	7.39	3.77	3.32	2.26	2.26	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	8.04	4.82	1.07	4.82	2.14	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	9.45	5.29	3.97	2.46	2.27	0.00	0.19	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	13.90	1.87	3.21	3.47	1.34	0.00	0.80	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	14.63	4.88	3.90	5.85	0.98	0.98	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	15.42	2.82	4.81	2.49	1.33	0.00	0.33	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	16.81	6.00	7.20	4.80	1.20	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	10.62	7.08	0.00	3.54	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	12.69	3.43	4.80	3.60	2.74	0.17	0.34	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	16.78	0.00	4.19	4.19	4.19	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	9.71	8.25	1.94	2.91	1.46	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	14.80	5.31	6.83	3.79	3.42	0.38	0.76	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	13.33	3.63	3.63	2.42	1.21	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	10.26	2.28	3.42	3.99	1.71	0.00	0.57	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	14.32	5.99	5.34	1.92	2.35	0.00	0.43	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	13.68	4.39	4.39	4.90	1.55	0.00	0.26	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	10.79	4.22	2.82	3.75	1.88	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	10.93	2.89	4.82	6.11	2.25	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	9.27	2.85	2.85	2.85	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	11.70	2.34	5.26	3.51	1.17	0.00	0.00	0.58
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	11.44	3.31	4.52	1.81	1.51	0.00	0.00	0.30
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	8.32	4.75	4.75	0.00	1.19	0.00	1.19	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	7.12	2.03	3.56	4.07	4.58	0.00	0.51	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	14.52	3.06	3.57	2.04	1.78	0.25	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	5.72	3.18	4.45	1.91	0.64	0.00	0.64	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	9.49	2.59	4.32	2.59	1.29	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	10.80	3.60	4.87	3.18	1.69	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	10.44	2.90	3.48	2.03	1.74	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	13.23	3.78	2.83	1.89	2.83	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	11.19	4.07	5.26	2.20	1.86	0.34	0.17	0.34
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	9.27	2.32	0.00	4.63	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	12.68	4.23	2.11	6.34	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	9.65	4.29	5.36	1.93	2.79	0.00	0.21	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	11.43	1.80	1.80	1.80	3.61	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	9.48	1.46	2.92	2.19	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	10.34	4.14	4.37	1.84	1.84	0.00	0.46	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	10.20	2.55	2.55	0.00	5.10	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	8.39	2.29	4.32	2.80	1.53	0.25	0.25	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	12.80	1.86	4.13	2.06	3.10	0.00	0.62	0.21
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	10.40	5.20	2.75	3.37	2.14	0.00	0.31	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	8.13	4.30	2.87	3.82	3.82	0.00	0.48	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	10.64	3.10	3.77	3.33	2.22	0.00	0.67	0.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	13.73	1.53	0.00	3.05	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	7.20	2.22	4.98	1.66	2.22	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	11.65	2.38	3.71	3.44	1.85	0.00	0.26	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	9.45	4.00	3.63	2.54	0.73	0.00	0.36	0.00
Astrocyte - cerebellum, donor1	11500-119F6	44.58	13.02	8.97	12.16	1.47	0.98	0.25	0.12
Astrocyte - cerebellum, donor2	11580-120F5	33.38	25.33	8.90	15.92	0.86	1.37	1.54	0.34
Astrocyte - cerebellum, donor3	11661-122F5	23.91	20.14	7.76	7.97	0.63	0.63	0.63	1.26
Astrocyte - cerebral cortex, donor1	11235-116D2	27.54	4.18	10.46	8.37	0.35	0.35	0.70	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	37.37	11.49	13.75	13.59	0.81	0.65	1.13	0.49
Astrocyte - cerebral cortex, donor3	11392-118C6	26.55	4.47	10.29	9.84	0.45	0.15	0.60	0.30
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	15.48	4.70	8.49	7.23	0.00	0.11	0.34	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	12.53	2.88	8.90	7.77	0.25	0.00	0.63	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	12.63	3.87	8.65	5.23	0.23	0.00	0.11	0.00
Basophils, donor1	12241-129G9	75.32	71.40	14.91	6.54	0.78	0.52	0.78	0.00
Basophils, donor2	12242-129H1	36.44	137.46	9.02	3.25	0.36	2.53	0.36	0.00
Basophils, donor3	12243-129H2	65.27	69.09	25.72	8.38	1.47	1.03	0.59	0.15
Bronchial Epithelial Cell, donor1	11511-119G8	4.74	10.78	3.45	1.08	0.86	0.00	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	28.35	17.83	9.60	15.09	1.37	0.00	0.91	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	14.35	7.17	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	33.89	5.65	6.90	11.93	1.26	0.00	1.26	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	29.32	2.50	14.97	13.52	1.46	0.00	1.25	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	5.30	8.29	3.68	5.07	0.46	0.23	0.00	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	6.12	8.46	1.98	2.52	0.36	0.18	0.36	0.18
Burkitt's lymphoma cell line:DAUDI	10422-106C8	158.40	37.72	52.15	58.12	1.24	0.82	1.24	0.52
Burkitt's lymphoma cell line:RAJI	10476-106I8	59.16	14.91	20.26	21.43	0.93	0.47	0.00	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	34.22	46.37	6.72	5.76	0.32	0.32	0.32	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	10.34	51.71	0.00	0.00	0.00	0.00	0.00	10.34
CD14+ Monocytes, donor1	11224-116B9	32.12	72.70	6.76	2.82	1.13	1.13	1.13	1.13
CD14+ Monocytes, donor2	11305-117B9	47.51	46.40	11.32	5.75	0.37	0.74	0.37	0.74
CD14+ Monocytes, donor3	11381-118B4	43.91	81.45	14.93	4.39	1.76	1.76	1.32	0.66
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	1.42	131.90	0.28	0.00	0.00	0.28	0.28	0.85
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	2.65	118.27	0.38	0.38	0.00	2.65	0.38	0.38
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	1.97	118.35	0.00	0.00	0.00	0.66	0.33	0.33
CD14+ monocytes - mock treated, donor1	11863-125A9	47.41	2.31	7.66	3.90	0.29	0.00	0.43	0.00
CD14+ monocytes - mock treated, donor2	11873-125C1	29.57	3.32	3.02	1.81	0.60	0.00	0.00	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	37.90	3.79	8.77	3.55	1.18	0.00	1.18	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	30.30	3.01	3.01	3.18	1.00	0.00	0.67	0.17
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	20.15	3.31	2.76	1.10	0.55	0.00	0.28	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	23.31	3.22	3.47	1.74	0.50	0.00	0.50	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	15.86	4.50	3.13	1.76	0.98	0.00	0.39	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	23.86	4.10	3.20	1.78	0.89	0.00	0.36	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	23.50	3.48	4.13	1.74	0.65	0.00	0.44	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	17.33	4.68	2.58	1.40	0.94	0.00	0.23	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	26.40	4.22	2.64	1.06	0.00	0.00	0.53	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	29.95	4.44	6.66	1.11	1.11	0.00	1.11	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	41.05	1.49	4.76	3.72	1.04	0.00	1.19	0.00
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	28.73	2.59	3.19	2.00	0.00	0.20	0.40	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	20.61	1.67	3.75	1.25	0.62	0.21	0.21	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	39.81	4.12	4.12	1.14	0.92	0.00	0.92	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	20.58	4.30	4.07	1.58	0.68	0.23	0.45	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	26.62	1.31	3.93	2.18	0.87	0.00	0.87	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	29.59	2.96	4.30	1.88	1.34	0.00	0.54	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	23.03	4.71	4.36	2.44	0.35	0.00	0.52	0.17
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	31.14	4.21	2.52	2.95	1.68	0.00	0.42	0.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	20.94	3.49	2.76	1.47	0.18	0.00	0.37	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	17.26	2.82	2.47	2.11	0.35	0.00	0.35	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	15.36	3.51	4.39	0.44	0.44	0.00	0.88	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	20.05	5.93	3.49	2.27	0.17	0.52	0.52	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	21.56	7.06	4.09	2.23	0.74	0.37	0.37	0.37
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	28.02	6.90	5.39	1.94	0.86	0.00	0.86	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	31.53	10.24	3.28	2.87	1.64	0.00	0.41	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	19.24	3.94	1.85	0.93	0.23	0.23	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	16.70	3.25	1.86	0.70	0.70	0.00	0.23	0.23
CD14+CD16+ Monocytes, donor1	11789-124B7	83.04	46.21	12.42	5.89	1.74	0.22	1.96	0.22
CD14+CD16+ Monocytes, donor2	11801-124D1	79.23	24.72	12.94	5.77	0.69	0.00	1.15	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	53.72	14.30	8.01	3.03	0.87	0.00	0.00	0.22
CD14+CD16- Monocytes, donor1	11788-124B6	131.43	45.47	15.88	7.63	1.56	0.31	1.09	0.47
CD14+CD16- Monocytes, donor2	11799-124C8	80.51	24.80	13.80	4.37	1.57	0.00	0.52	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	77.59	14.72	14.94	4.91	0.89	0.22	0.89	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	102.84	28.07	16.08	3.32	1.02	0.00	0.77	0.26
CD14-CD16+ Monocytes, donor2	11800-124C9	103.63	20.86	13.61	7.03	0.88	0.00	1.32	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	72.01	13.90	13.90	4.84	0.21	0.00	0.42	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	0.00	174.78	0.00	0.00	0.00	4.06	0.00	2.03
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	4.07	213.56	2.71	0.68	0.00	6.10	0.68	2.03
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	5.18	185.37	1.04	1.04	0.00	4.14	0.00	2.07
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	6.40	228.67	2.13	0.53	0.53	5.33	0.53	3.20
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	4.82	230.51	1.07	1.07	0.54	3.75	0.00	1.07
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	7.02	174.78	0.00	0.00	0.70	2.81	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	3.92	141.18	0.78	1.57	0.00	0.00	0.00	3.14
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	2.64	152.92	0.00	2.64	0.00	1.32	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	0.82	368.21	0.00	0.00	0.00	5.75	2.47	4.93
CD19+ B Cells, donor2	11624-122B4	6.53	224.16	1.45	0.00	0.00	2.90	0.73	2.18
CD19+ B Cells, donor3	11705-123B4	2.02	316.02	0.00	0.00	0.00	7.57	1.01	3.03
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	208.09	2.02	66.27	50.10	0.00	0.00	0.81	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	210.93	0.00	47.54	46.34	1.20	0.00	0.40	0.00
CD34+ Progenitors, donor1	11545-120B6	10.04	51.21	1.00	1.00	1.00	1.00	0.00	1.00
CD34+ Progenitors, donor2	11625-122B5	4.49	46.07	0.56	0.00	0.56	2.81	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	57.11	31.56	15.03	9.39	0.00	0.38	0.38	0.75
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	55.47	31.57	11.05	8.79	0.23	0.23	0.23	0.23
CD4+ T Cells, donor1	11225-116C1	4.28	403.12	0.00	1.07	0.00	4.28	0.36	2.86
CD4+ T Cells, donor2	11306-117C1	5.51	380.28	1.22	0.61	0.00	4.29	1.22	1.84
CD4+ T Cells, donor3	11382-118B5	5.79	422.11	2.74	0.61	0.00	9.45	1.83	2.13
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	129.15	159.27	17.87	12.00	1.02	1.28	2.04	0.77
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	110.50	151.15	19.99	11.23	0.22	0.45	0.67	1.35
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	114.70	154.65	18.97	14.09	0.00	2.30	1.72	2.59
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	1.42	715.88	0.47	0.47	0.00	15.65	1.90	10.90
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	1.40	687.57	0.00	0.00	0.00	16.15	0.00	9.13
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	0.00	725.17	0.00	3.30	0.00	9.89	0.00	3.30
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	139.17	63.15	14.89	12.72	1.73	0.43	2.02	0.58
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	181.83	49.99	33.21	19.15	1.02	0.34	1.86	0.34
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	158.14	51.26	28.37	18.86	1.29	0.16	2.74	1.13
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	11.66	300.36	1.79	1.79	0.00	6.28	0.90	5.83
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	10.13	295.23	1.40	0.70	0.00	5.94	0.35	4.19
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	7.48	196.67	0.44	2.20	0.00	1.32	0.44	1.76
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	136.19	146.31	14.34	10.54	1.26	2.53	2.11	1.69
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	137.96	121.75	16.83	12.67	0.83	2.08	2.70	0.83
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	121.29	117.28	15.04	15.04	0.67	1.67	1.34	2.34
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	5.98	821.51	0.27	0.54	0.00	22.84	1.09	13.05
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	2.14	899.32	0.00	0.54	0.00	17.69	2.14	16.61
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	8.97	821.30	1.79	0.00	0.00	7.17	3.59	1.79
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	222.70	124.79	23.73	16.50	1.85	1.30	0.93	0.74
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	174.38	114.59	30.11	15.60	1.52	1.08	2.17	0.87
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	232.22	140.17	31.31	23.75	1.26	0.84	2.52	0.63
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	10.62	544.54	6.57	1.52	1.01	10.11	1.01	7.08
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	9.10	467.48	1.30	1.73	0.00	7.80	0.00	7.37
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	8.72	474.60	3.49	0.44	0.00	3.49	0.87	3.92
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	26.72	474.58	7.42	3.46	0.00	12.37	0.00	4.95
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	24.93	457.90	3.69	2.77	0.00	16.62	0.92	5.54
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	27.92	470.39	6.98	6.98	0.00	6.98	1.40	2.79
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	28.52	585.43	4.43	3.88	0.00	12.74	0.83	5.54
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	38.77	535.93	3.68	5.15	0.49	14.48	0.74	5.40
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	33.88	374.22	4.62	1.54	0.00	13.86	0.00	6.16
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	32.59	411.84	8.24	3.58	0.00	6.80	2.15	3.22
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	37.39	397.49	4.15	2.77	0.00	8.31	0.00	9.69
CD8+ T Cells, donor1	11226-116C2	11.79	413.17	1.64	2.29	0.00	8.84	0.00	3.60
CD8+ T Cells, donor2	11307-117C2	7.88	370.18	2.63	1.50	0.00	7.13	2.25	1.13
CD8+ T Cells, donor3	11383-118B6	5.81	562.80	2.78	2.02	0.00	11.36	2.52	4.80
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	18.35	2.06	4.59	2.75	0.46	0.00	0.69	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	15.82	0.72	4.07	4.07	0.24	0.00	0.48	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	17.51	2.19	1.64	3.01	0.27	0.00	1.09	0.27
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	7.21	3.30	2.10	1.80	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	13.44	3.36	2.88	2.88	0.24	0.00	0.24	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	14.10	3.18	2.96	2.05	0.68	0.00	0.45	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	21.51	1.52	3.04	4.13	0.43	0.00	0.22	0.22
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	18.42	0.79	3.95	4.74	0.26	0.00	0.26	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	20.64	1.88	4.69	3.75	0.23	0.00	0.47	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	17.21	2.11	3.62	3.32	0.91	0.00	0.60	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	18.88	4.94	2.03	2.32	0.29	0.00	0.87	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	20.52	2.40	2.93	3.20	0.80	0.00	0.80	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	14.88	3.94	2.63	1.75	0.44	0.00	0.44	0.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	14.57	4.55	3.64	2.28	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	6.71	2.98	0.75	2.98	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	17.65	1.80	2.52	2.88	0.36	0.00	0.36	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	17.55	3.74	2.01	3.45	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	15.32	3.06	2.83	2.83	0.00	0.00	0.24	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	20.28	0.95	4.44	3.49	0.00	0.32	0.32	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	15.69	3.08	6.15	5.54	0.00	0.00	0.62	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	23.72	2.89	4.17	4.17	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	10.71	2.29	4.97	3.06	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	16.16	1.18	1.97	2.36	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	10.59	1.51	3.03	0.76	0.00	0.76	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	7.23	5.62	3.21	1.61	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	18.19	6.99	2.80	6.29	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	12.02	8.01	3.01	6.01	0.00	1.00	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	9.14	14.62	0.00	3.66	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	19.27	25.20	4.94	6.92	0.99	0.00	0.00	0.00
Cardiac Myocyte, donor3	11686-122I3	20.31	13.05	8.94	5.58	0.74	0.42	0.21	0.00
Chondrocyte - de diff, donor1	11261-116G1	13.87	0.00	4.16	1.73	0.35	0.00	0.00	0.00
Chondrocyte - de diff, donor2	11338-117F6	15.28	0.00	4.98	1.78	1.42	0.00	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	13.31	0.11	5.92	3.19	0.57	0.00	0.23	0.00
Chondrocyte - re diff, donor2	11339-117F7	21.49	1.79	3.58	4.48	0.90	0.00	0.90	0.00
Chondrocyte - re diff, donor3	11411-118E7	10.11	2.02	8.90	3.64	2.02	0.40	0.40	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	10.21	20.89	5.16	4.13	0.34	2.52	0.11	0.80
Ciliary Epithelial Cells, donor2	11323-117D9	13.68	11.54	7.48	6.63	0.64	1.50	0.21	0.21
Ciliary Epithelial Cells, donor3	11399-118D4	14.69	19.74	5.75	6.46	0.27	1.68	0.18	1.06
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	20.91	34.30	6.42	3.67	0.55	1.56	0.28	0.92
Corneal Epithelial Cells, donor1	11526-119I5	14.05	22.84	7.03	3.95	0.44	0.44	0.00	0.44
Corneal Epithelial Cells, donor2	11606-120I4	10.24	3.41	4.55	2.28	1.14	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	17.64	13.29	5.88	5.88	1.28	0.00	0.26	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	55.80	3.63	7.26	1.98	0.83	0.00	0.33	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	55.83	1.26	5.36	1.58	0.32	0.00	0.00	0.32
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	27.61	0.00	6.90	3.45	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	68.57	5.94	8.86	3.46	1.08	0.11	1.19	0.00
Dendritic Cells - plasmacytoid, donor1	11228-116C4	67.30	98.73	14.01	2.39	0.68	0.00	0.34	0.34
Dendritic Cells - plasmacytoid, donor2	11309-117C4	99.24	53.54	27.42	8.49	0.65	0.00	0.00	0.65
Dendritic Cells - plasmacytoid, donor3	11385-118B8	57.59	86.14	10.16	5.81	0.48	0.00	0.48	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	29.02	3.34	10.84	7.17	1.50	0.17	0.17	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	26.99	9.98	5.28	12.91	2.35	0.00	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	36.20	5.66	9.90	7.64	1.13	0.00	0.57	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	24.38	9.83	6.68	7.86	1.57	0.00	0.39	0.00
Endothelial Cells - Artery, donor1	11264-116G4	28.21	5.82	7.85	8.44	1.75	0.00	0.58	0.58
Endothelial Cells - Artery, donor2	11341-117F9	34.12	12.71	8.00	13.41	1.18	0.00	0.71	0.00
Endothelial Cells - Artery, donor3	11413-118E9	54.17	11.04	15.08	15.95	2.28	0.35	0.88	0.18
Endothelial Cells - Lymphatic, donor1	11236-116D3	14.85	8.87	4.21	7.54	1.11	0.00	0.22	0.22
Endothelial Cells - Lymphatic, donor2	11317-117D3	20.08	7.30	6.39	4.56	0.30	0.00	0.00	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	22.27	7.05	2.54	4.23	1.13	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	19.31	8.02	5.05	7.13	2.08	0.59	0.59	0.30
Endothelial Cells - Microvascular, donor2	11342-117G1	23.43	3.12	3.12	5.21	1.56	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	10.07	11.91	3.83	2.98	1.13	0.28	0.00	0.14
Endothelial Cells - Thoracic, donor1	11266-116G6	44.81	3.60	8.80	12.00	2.00	0.00	0.80	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	39.83	14.68	7.86	12.05	0.52	0.00	2.10	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	28.70	6.96	8.20	9.57	1.86	0.12	0.37	0.12
Endothelial Cells - Umbilical vein, donor2	11324-117E1	18.25	7.60	5.00	8.47	0.65	0.00	0.00	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	32.36	6.96	10.14	11.60	0.85	0.00	0.37	0.12
Endothelial Cells - Vein, donor1	11267-116G7	37.54	5.69	14.79	9.10	4.55	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	41.21	10.48	10.48	13.27	2.79	0.70	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	22.92	7.22	9.42	8.64	1.73	0.00	0.00	0.00
Eosinophils, donor1	12244-129H3	91.48	320.19	0.00	0.00	0.00	0.00	0.00	15.25
Eosinophils, donor2	12245-129H4	26.40	201.33	18.15	4.95	1.65	1.65	0.00	1.65
Eosinophils, donor3	12246-129H5	74.90	256.81	10.70	7.13	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	7.33	11.48	7.09	3.91	0.24	0.24	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	0.00	8.32	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	48.81	0.00	16.27	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	8.62	0.00	6.16	2.87	0.00	0.00	0.41	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	7.12	0.44	4.38	4.71	1.31	0.00	0.88	0.00
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	8.02	1.63	5.53	3.90	0.54	0.22	0.33	0.00
Fibroblast - Aortic Adventitial, donor1	11245-116E3	14.43	0.97	6.79	5.82	1.09	0.00	0.49	0.00
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	7.92	0.68	3.55	2.05	1.50	0.00	0.00	0.00
Fibroblast - Aortic Adventitial, donor2	11326-117E3	10.65	0.74	4.43	2.95	0.84	0.00	0.32	0.00
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	6.85	0.79	1.32	3.43	0.53	0.00	0.00	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	16.28	5.32	9.30	9.30	0.33	0.00	0.66	0.00
Fibroblast - Cardiac, donor1	11268-116G8	28.58	4.08	6.80	6.35	1.81	0.00	0.91	0.00
Fibroblast - Cardiac, donor2	11345-117G4	24.25	0.76	6.06	5.31	2.27	0.00	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	26.02	5.36	10.57	10.41	0.95	0.00	0.79	0.16
Fibroblast - Cardiac, donor4	11452-119A3	40.31	15.76	11.21	4.24	1.52	0.00	0.00	0.30
Fibroblast - Cardiac, donor5	11456-119A7	18.02	34.26	6.22	8.12	0.89	0.89	0.25	0.38
Fibroblast - Cardiac, donor6	11460-119B2	34.26	21.83	7.58	7.73	0.76	0.76	0.91	0.45
Fibroblast - Choroid Plexus, donor1	11492-119E7	27.07	24.39	5.09	5.09	0.67	3.22	0.00	1.47
Fibroblast - Choroid Plexus, donor2	11572-120E6	12.94	30.20	3.02	2.16	2.16	0.43	0.00	0.86
Fibroblast - Choroid Plexus, donor3	11653-122E6	19.04	8.79	10.25	13.18	0.00	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	11.30	19.60	6.92	7.84	0.46	1.15	0.00	1.15
Fibroblast - Conjunctival, donor3	11692-122I9	8.14	24.25	1.70	2.04	0.34	0.85	0.00	0.34
Fibroblast - Dermal, donor1	11269-116G9	7.98	11.74	5.17	2.11	1.17	0.00	0.00	0.00
Fibroblast - Dermal, donor2	11346-117G5	27.36	8.96	9.43	4.72	0.47	0.00	0.00	0.47
Fibroblast - Dermal, donor3	11418-118F5	13.42	11.36	6.41	2.66	1.09	0.00	0.60	0.24
Fibroblast - Dermal, donor4	11450-119A1	17.97	6.22	7.69	9.38	0.34	0.00	0.57	0.00
Fibroblast - Dermal, donor5	11454-119A5	15.18	6.11	6.63	6.28	0.87	0.00	0.35	0.00
Fibroblast - Dermal, donor6	11458-119A9	22.58	6.66	9.26	9.42	0.65	0.16	1.14	0.00
Fibroblast - Gingival, donor1	11237-116D4	17.07	22.91	9.16	3.33	0.83	0.62	0.00	0.42
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	15.72	0.79	4.98	2.88	2.36	0.00	0.79	0.00
Fibroblast - Gingival, donor2	11318-117D4	26.75	24.51	8.83	6.85	0.79	0.79	1.19	0.13
Fibroblast - Gingival, donor3	11394-118C8	10.93	26.88	6.38	4.74	1.35	0.39	0.19	0.77
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	12.47	4.16	5.19	4.16	0.00	0.00	1.04	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	12.33	2.29	4.58	3.70	1.23	0.00	0.88	0.00
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	22.29	1.56	7.79	5.46	0.31	0.00	0.31	0.00
Fibroblast - Gingival, donor6 (control)	11922-125H5	16.90	0.68	5.27	5.14	0.95	0.00	0.27	0.00
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	37.41	0.35	11.65	13.76	1.76	0.00	0.00	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	17.40	0.58	7.46	4.97	0.73	0.00	0.58	0.00
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	15.41	0.41	4.50	2.86	0.95	0.00	0.41	0.00
Fibroblast - Gingival, donor8 (control)	11926-125H9	22.82	0.33	7.24	6.25	0.66	0.00	0.66	0.00
Fibroblast - Gingival, donor9 (control)	11927-125I1	6.31	1.03	3.67	2.35	0.73	0.00	0.44	0.15
Fibroblast - Lung, donor1	11270-116H1	19.03	53.01	9.52	5.44	1.36	4.08	0.00	2.72
Fibroblast - Lung, donor2	11347-117G6	10.45	43.27	2.98	1.49	0.00	0.00	0.00	2.98
Fibroblast - Lung, donor3	11419-118F6	22.37	72.17	7.60	4.64	1.48	1.90	0.42	2.11
Fibroblast - Lymphatic, donor1	11506-119G3	52.48	29.99	8.33	5.83	1.67	0.83	0.00	0.83
Fibroblast - Lymphatic, donor2	11586-120G2	30.77	12.59	5.59	9.79	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	26.03	29.95	9.80	8.96	1.68	0.56	1.12	0.84
Fibroblast - Mammary, donor1	11540-120B1	39.38	22.33	18.67	10.96	0.81	0.00	0.41	0.81
Fibroblast - Mammary, donor2	11620-122A9	31.95	31.95	3.99	11.98	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	17.87	17.87	5.96	5.96	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	15.52	18.23	7.76	5.24	0.19	0.19	0.00	1.55
Fibroblast - Periodontal Ligament, donor2	11319-117D5	20.63	19.26	10.47	8.95	0.00	0.76	0.15	0.46
Fibroblast - Periodontal Ligament, donor3	11395-118C9	29.68	10.10	12.85	7.65	0.31	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	15.26	0.76	6.11	10.69	1.14	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	16.20	0.00	5.94	6.48	0.27	0.00	1.35	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	11.71	4.18	5.22	3.02	0.12	0.00	0.70	0.00
Fibroblast - Pulmonary Artery, donor1	11250-116E8	32.50	20.23	9.95	8.18	0.77	0.66	0.88	0.33
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	92.45	14.83	20.32	14.02	1.22	0.20	0.41	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	31.41	16.04	12.70	9.35	2.00	0.00	0.67	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	16.61	17.40	6.72	6.72	1.19	0.00	0.40	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	15.68	0.20	1.79	3.97	0.99	0.00	0.40	0.00
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	6.75	0.89	2.49	1.07	0.71	0.00	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	13.40	0.00	4.73	2.76	0.79	0.00	0.20	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	18.35	0.60	2.11	4.81	0.30	0.00	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	12.41	1.19	3.35	1.51	0.65	0.00	0.11	0.00
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	12.65	0.51	2.78	2.28	0.25	0.00	0.00	0.00
Fibroblast - skin normal, donor1	11553-120C5	13.78	0.00	4.59	2.13	0.98	0.00	0.16	0.00
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	18.45	0.00	7.22	4.01	0.40	0.00	0.20	0.00
Fibroblast - skin normal, donor2	11561-120D4	19.69	1.11	8.04	4.62	0.50	0.00	0.80	0.00
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	20.55	0.60	4.84	1.51	0.91	0.00	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	10.11	1.24	3.40	1.41	0.41	0.00	0.17	0.00
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	7.69	2.91	2.39	1.71	1.03	0.00	0.68	0.00
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	7.88	0.00	1.31	4.60	1.64	0.00	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	23.12	0.43	6.92	4.90	1.70	0.00	0.43	0.00
Fibroblast - skin walker warburg, donor1	11554-120C6	18.22	0.34	5.57	5.74	1.01	0.00	0.00	0.00
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	4.86	0.16	4.08	1.25	1.41	0.00	0.78	0.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	6.10	25.27	2.61	2.61	0.87	0.00	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	14.22	2.08	7.80	2.95	1.91	0.00	0.00	0.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	25.24	1.30	10.93	5.73	2.08	0.00	0.78	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	16.61	2.81	11.24	4.85	0.77	0.00	1.02	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	6.89	0.00	3.06	11.48	0.00	0.00	0.77	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	2.55	0.64	1.28	9.57	0.00	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	2.00	0.00	2.28	12.84	0.29	0.00	0.29	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	1.65	1.10	1.93	9.10	0.00	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	3.65	1.60	2.28	5.02	0.00	0.00	0.46	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	1.39	0.79	2.77	11.89	0.20	0.20	0.40	0.20
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	2.91	1.59	2.11	7.40	0.00	0.26	0.26	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	5.87	1.63	2.28	5.22	0.00	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	1.33	0.44	0.44	9.73	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	3.53	0.71	3.25	11.02	0.71	0.00	0.42	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	6.03	1.23	2.59	8.50	0.25	0.12	0.12	0.12
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	2.15	0.27	1.34	10.75	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	8.80	2.85	3.22	8.55	0.00	0.00	0.37	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	5.12	1.94	3.32	8.44	0.00	0.00	0.14	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	1.63	0.61	2.44	7.73	0.00	0.00	0.41	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	9.36	4.34	5.70	7.76	0.00	0.46	0.00	0.23
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	5.85	3.49	2.37	6.85	0.12	0.50	0.25	0.12
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	3.50	2.84	1.53	7.21	0.22	0.22	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	10.93	8.27	4.73	3.84	0.30	0.59	0.00	0.30
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	9.86	4.45	3.97	6.36	0.16	0.16	0.32	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	9.83	2.46	4.47	7.82	0.00	0.22	0.67	0.22
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	9.07	3.83	4.44	4.84	0.20	0.00	0.81	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	13.40	4.24	5.26	6.11	0.17	0.17	0.00	0.17
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	10.55	6.12	3.64	5.41	0.00	0.53	0.18	0.18
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	15.61	6.24	7.60	4.79	0.42	0.10	0.21	0.10
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	11.78	4.27	4.78	4.27	0.34	0.17	0.34	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	10.73	3.76	6.86	5.75	0.33	0.22	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	11.40	6.41	5.66	5.57	0.17	0.25	0.08	0.08
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	7.96	5.10	3.68	3.68	0.20	0.61	0.20	0.20
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	9.49	6.81	5.16	3.51	0.21	0.00	0.21	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	9.57	2.77	4.27	4.27	0.23	0.00	0.23	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	10.84	5.34	5.67	5.00	0.50	0.33	1.33	0.17
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	7.05	8.60	5.95	3.97	0.44	0.88	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	10.82	5.78	6.27	4.92	0.49	0.12	0.49	0.12
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	10.21	4.38	3.89	5.51	0.49	0.32	0.49	0.16
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	7.38	9.30	3.85	6.74	0.00	0.32	0.32	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	9.95	5.87	5.31	6.73	0.38	0.00	0.28	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	10.91	4.27	5.69	3.64	0.16	0.16	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	9.73	5.78	4.26	5.17	0.00	0.00	0.00	0.30
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	12.86	4.50	5.85	5.33	0.42	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	8.12	5.27	4.83	3.51	0.66	0.44	0.00	0.22
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	12.34	6.17	5.05	4.77	0.56	0.00	0.00	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	13.89	5.93	7.22	5.18	0.83	0.09	0.37	0.19
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	15.24	7.22	6.69	8.29	1.07	0.53	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	15.91	4.28	7.80	5.97	0.77	0.00	0.77	0.15
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	15.80	5.18	7.25	6.61	0.52	0.00	0.39	0.13
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	9.22	7.86	5.42	5.96	1.08	0.00	0.54	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	14.75	10.69	6.27	4.42	0.55	0.37	0.37	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	12.50	14.26	5.04	2.85	0.22	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	6.94	4.96	7.93	1.98	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	19.65	13.06	7.26	5.01	0.26	0.00	0.40	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	14.73	14.53	4.84	3.43	2.02	0.20	0.40	0.20
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	21.10	11.95	8.64	4.83	0.51	0.51	0.00	0.25
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	1.79	0.20	1.99	12.34	0.00	0.00	0.20	0.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	1.08	0.00	1.85	12.02	0.62	0.00	0.15	0.00
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	1.84	0.20	1.84	18.41	0.41	0.00	0.61	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	7.82	1.25	3.13	10.95	0.00	0.00	0.31	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	3.39	0.28	2.54	9.04	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	1.38	0.00	1.38	7.38	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	7.42	0.00	2.47	4.95	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	3.09	0.39	2.32	4.25	0.00	0.39	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	9.63	0.00	1.60	6.42	0.00	1.60	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	0.00	1.74	0.00	5.22	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	4.56	0.98	1.95	4.23	0.00	0.33	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	4.94	2.06	0.41	5.35	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	0.00	0.00	3.33	3.33	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	5.87	3.36	1.68	4.75	0.28	0.00	0.28	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	4.90	1.96	0.98	5.56	0.00	0.33	0.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	3.36	2.52	1.68	4.19	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	7.63	1.91	3.50	3.82	0.00	0.32	0.95	0.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	7.81	1.36	0.34	5.09	0.34	0.34	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	8.35	2.09	6.26	12.53	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	8.59	2.86	3.44	5.73	0.00	0.00	0.57	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	4.74	2.07	2.37	5.92	0.00	0.30	0.30	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	5.08	1.69	5.08	6.78	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	10.36	3.73	4.14	5.38	0.00	0.83	1.66	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	5.52	1.84	1.61	3.91	0.00	0.46	0.23	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	15.81	5.27	5.27	10.54	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	6.92	1.54	2.69	2.69	0.38	0.38	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	11.73	1.63	1.63	3.91	0.00	0.33	0.00	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	6.02	0.67	2.01	3.34	0.67	0.67	0.00	0.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	8.09	2.70	0.77	2.31	0.00	0.00	1.16	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	10.27	1.71	2.05	4.45	1.03	0.00	0.00	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	0.00	0.00	4.97	9.94	2.48	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	5.19	1.42	3.30	7.08	0.00	0.00	0.00	0.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	10.86	1.21	4.22	4.83	0.00	0.00	0.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	6.61	3.05	6.61	4.58	0.00	0.51	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	11.17	1.20	2.79	3.99	0.40	0.00	0.40	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	6.91	2.47	2.96	3.95	0.49	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	11.80	2.36	3.54	7.08	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	8.17	2.33	4.08	6.42	0.58	0.00	0.00	0.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	7.02	2.19	6.58	3.07	0.00	0.88	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	7.63	6.78	3.39	2.54	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	5.97	1.79	4.18	2.39	0.60	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	5.34	1.94	3.88	5.34	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	15.98	0.00	4.57	1.14	1.14	0.00	1.14	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	17.88	0.42	8.73	3.33	1.66	0.00	0.42	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	48.35	4.50	5.62	7.87	1.12	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	10.78	29.50	3.81	1.90	1.59	0.63	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	12.53	21.72	3.34	2.92	1.67	0.00	0.42	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	90.74	0.58	20.77	24.02	0.70	0.00	1.51	0.00
Hep-2 cells mock treated, biol_rep2	11899-125E9	91.66	0.51	21.27	24.31	0.84	0.00	1.18	0.00
Hep-2 cells mock treated, biol_rep3	11900-125F1	74.17	0.23	19.34	21.39	0.23	0.00	1.14	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	91.60	0.33	20.22	28.53	1.42	0.00	3.17	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	90.26	0.21	21.92	28.58	1.29	0.00	1.29	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	69.54	0.22	18.08	21.53	0.65	0.00	1.29	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	61.65	0.25	14.94	16.19	0.87	0.00	1.25	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	56.10	0.17	14.92	12.87	1.03	0.00	0.17	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	49.98	0.32	14.10	8.97	0.32	0.00	0.96	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	24.06	15.11	7.28	9.51	2.24	0.00	1.12	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	33.33	6.92	15.15	15.58	0.43	0.00	0.43	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	44.94	7.93	7.93	15.86	2.64	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	45.50	19.40	11.99	9.52	0.71	1.06	0.00	0.35
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	45.04	31.24	11.62	11.62	0.73	0.00	1.45	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	37.42	24.48	13.29	14.69	0.70	1.22	0.52	1.05
Hepatocyte, donor1	11523-119I2	1.21	1.21	0.00	1.21	0.00	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	8.62	24.78	2.15	0.00	0.00	0.00	0.00	0.00
Hepatocyte, donor3	11684-122I1	5.52	14.11	4.91	2.45	0.61	0.00	0.00	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	389.65	67.88	49.60	48.95	3.92	2.61	6.53	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	11.19	5.42	1.92	1.57	0.17	0.00	0.17	0.17
Iris Pigment Epithelial Cells, donor1	11530-119I9	12.76	12.07	6.04	4.67	0.69	0.27	0.00	0.27
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	156.01	15.92	76.41	63.68	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	73.43	33.38	40.05	33.38	0.00	0.00	6.68	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	243.75	27.08	81.25	81.25	27.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	124.59	4.15	45.68	66.45	0.00	0.00	1.38	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	105.11	15.02	60.06	52.56	5.01	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	94.95	23.74	23.74	106.81	11.87	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	140.96	25.63	41.01	58.95	0.00	0.00	5.13	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	141.69	9.14	54.85	73.13	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	159.18	12.99	48.73	89.34	4.87	0.00	1.62	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	131.72	6.67	38.35	75.03	3.33	0.00	6.67	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	108.92	29.04	58.09	47.20	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	149.55	18.53	50.29	59.56	0.00	0.00	3.97	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	116.41	6.65	64.30	59.87	3.33	0.00	2.22	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	130.96	20.95	57.62	78.57	5.24	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	153.06	9.45	54.17	64.88	0.00	0.00	3.15	1.26
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	129.92	10.83	64.96	61.86	0.00	0.00	7.73	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	131.71	0.00	73.17	73.17	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	148.59	6.46	63.96	70.42	1.29	0.65	3.23	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	123.96	17.71	67.62	67.62	4.83	0.00	1.61	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	59.74	23.90	71.69	119.48	11.95	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	159.72	13.85	64.38	70.08	2.44	0.00	4.07	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	176.32	10.50	58.35	60.03	1.26	0.00	4.20	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	57.49	28.74	14.37	57.49	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	174.40	11.25	57.87	81.17	2.41	0.00	4.82	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	122.80	21.24	44.32	55.40	1.85	0.00	0.92	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	120.65	0.00	30.16	45.24	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	137.36	12.27	58.06	58.53	2.83	0.00	4.72	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	109.74	7.26	58.05	41.72	5.44	0.91	2.72	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	88.45	14.74	29.48	73.71	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	157.11	11.84	75.33	63.49	2.15	0.00	3.23	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	177.86	16.52	80.04	68.61	1.27	0.00	2.54	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	164.30	65.72	65.72	147.87	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	188.75	12.12	58.03	81.62	2.55	0.00	5.10	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	153.10	9.11	76.55	56.50	1.82	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	15.80	0.00	63.22	47.41	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	173.52	11.43	69.26	74.26	0.71	0.00	3.57	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	165.92	3.32	39.82	56.41	3.32	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	166.79	0.00	41.70	104.24	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	166.68	7.72	57.72	59.88	2.16	0.00	2.47	0.31
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	177.36	8.78	63.22	75.51	5.27	0.00	3.51	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	113.15	9.43	34.57	37.72	3.14	0.00	6.29	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	182.19	7.65	70.23	68.84	2.09	0.00	2.09	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	181.47	19.92	84.10	84.10	2.21	0.00	2.21	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	94.02	16.21	51.87	58.36	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	181.36	9.59	74.11	79.35	0.87	0.00	5.23	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	128.24	15.75	80.99	80.99	2.25	0.00	6.75	2.25
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	160.29	10.45	59.24	73.18	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	156.82	17.07	94.94	102.41	1.07	0.00	2.13	1.07
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	145.47	13.85	44.33	63.73	2.77	0.00	1.39	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	153.88	5.70	54.14	45.59	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	156.47	13.81	63.51	65.35	3.68	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	105.89	15.13	66.56	93.78	6.05	0.00	3.03	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	142.80	18.63	80.71	43.46	0.00	0.00	12.42	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	104.68	15.86	72.96	66.61	4.23	0.00	2.11	0.00
Keratinocyte - epidermal, donor1	11272-116H3	15.34	5.06	5.88	4.24	0.73	0.08	0.00	0.08
Keratinocyte - epidermal, donor2	11349-117G8	4.10	10.54	4.69	5.27	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	18.08	8.14	7.48	5.58	0.85	0.00	0.38	0.09
Keratinocyte - oral, donor1	11251-116E9	8.51	30.20	4.88	3.18	0.23	0.45	0.00	0.45
Keratocytes, donor1	11527-119I6	8.60	78.74	7.56	5.50	1.03	4.13	0.00	2.41
Keratocytes, donor2	11607-120I5	25.78	18.75	10.55	9.37	1.17	0.00	0.00	1.17
Keratocytes, donor3	11688-122I5	7.90	64.02	3.36	1.19	0.59	1.58	0.59	2.96
Krukenberg tumor cell line:HSKTC	10687-109F3	6.59	6.59	10.99	4.40	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	26.97	14.02	5.39	10.79	1.08	0.00	1.08	0.00
Lens Epithelial Cells, donor2	11609-120I7	4.38	6.00	3.81	1.96	0.58	0.12	0.12	0.00
Lens Epithelial Cells, donor3	11690-122I7	16.85	21.29	5.15	4.04	1.21	0.91	0.10	1.01
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	13.64	4.51	4.51	3.44	1.42	0.12	0.59	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	10.88	3.63	2.51	2.51	0.28	0.00	0.28	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	8.34	7.71	1.89	2.05	0.63	0.47	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	9.68	4.84	4.84	3.23	1.08	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	14.18	6.30	1.89	1.89	0.32	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	7.44	8.19	1.19	2.48	1.19	0.00	0.00	0.11
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	5.75	4.10	3.28	3.28	1.23	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	10.62	3.03	1.52	3.79	0.51	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	9.57	5.49	1.97	1.69	0.99	0.00	0.14	0.14
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	8.70	6.33	0.79	3.96	0.40	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	9.31	5.04	2.33	1.55	0.58	0.00	0.39	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	9.81	10.00	3.52	3.15	0.56	0.19	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	11.15	4.18	2.79	2.44	0.35	0.00	0.70	0.35
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	10.50	6.20	3.10	2.15	0.48	0.48	0.72	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	9.89	6.73	1.65	2.88	0.55	0.00	0.55	0.14
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	10.47	4.00	2.46	2.46	0.00	0.00	0.00	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	10.29	5.61	2.81	4.68	0.62	0.00	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	10.80	9.52	2.38	2.93	1.28	0.37	0.37	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	10.53	6.58	3.29	2.30	0.66	0.33	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	12.89	4.10	1.17	4.69	1.46	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	13.44	8.46	2.24	3.24	1.24	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	6.30	3.88	0.97	6.30	0.48	0.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	11.04	3.50	3.23	3.50	0.27	0.00	0.27	0.27
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	11.96	6.36	1.51	2.72	0.91	0.00	0.00	0.15
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	9.85	4.67	1.56	4.67	0.52	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	10.89	4.61	1.26	3.35	0.63	0.21	0.00	0.42
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	12.33	7.22	2.86	2.41	0.30	0.15	0.15	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	11.69	2.75	1.38	6.19	0.69	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	12.79	5.46	3.39	5.08	0.38	0.19	0.38	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	11.66	8.16	2.12	2.23	0.64	0.21	0.21	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	6.78	5.33	1.45	5.33	0.48	0.00	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	11.58	5.29	4.30	2.65	0.00	0.33	0.33	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	9.17	7.68	2.85	2.48	0.87	0.37	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	10.74	6.66	2.22	5.55	1.11	0.74	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	10.13	5.19	3.21	2.96	0.49	0.49	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	9.21	9.49	3.02	2.61	0.55	0.69	0.14	0.14
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	10.61	5.47	1.93	2.89	0.64	0.00	0.64	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	12.48	6.09	3.04	4.87	0.30	0.30	0.30	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	9.10	9.24	2.80	2.80	0.84	0.56	0.00	0.14
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	12.80	5.33	1.78	2.13	1.07	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	10.67	5.82	1.45	1.94	0.97	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	11.20	10.27	1.71	3.27	1.24	0.62	0.31	0.16
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	13.25	6.09	4.66	2.15	1.07	0.00	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	11.43	5.23	2.94	4.90	0.33	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	9.18	8.24	3.06	3.77	2.12	0.00	0.24	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	14.23	6.81	4.70	3.71	0.37	0.00	0.50	0.12
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	11.53	4.10	3.07	4.87	0.26	0.51	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	8.95	6.27	2.09	2.98	0.30	0.30	0.00	0.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	6.80	9.06	0.00	6.80	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	17.64	4.60	8.44	1.53	2.30	0.00	1.53	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	11.13	4.45	6.68	5.20	0.74	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	17.35	5.08	5.50	1.69	1.27	0.00	1.27	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	16.18	3.52	7.03	3.52	0.70	0.00	0.70	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	17.75	2.80	5.60	0.93	1.87	0.00	1.87	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	10.82	4.64	5.15	0.52	1.55	0.00	0.52	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	14.27	4.76	4.76	3.57	2.38	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	12.67	4.75	5.20	2.26	2.04	0.23	0.00	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	9.89	4.36	4.07	3.49	0.87	0.29	0.29	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	16.66	5.85	6.75	2.25	1.80	0.00	0.90	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	20.46	5.96	9.48	2.57	1.22	0.27	0.54	0.14
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	17.46	3.08	3.08	3.08	1.54	1.03	1.03	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	12.70	4.23	4.59	3.18	1.06	0.71	0.00	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	13.99	4.00	5.33	1.33	0.67	0.00	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	13.75	6.11	5.60	3.06	1.53	0.00	2.04	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	14.67	7.20	9.87	5.87	2.13	0.00	1.07	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	13.60	4.53	7.56	3.59	1.51	0.00	0.76	0.19
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	17.18	4.91	5.52	3.68	3.07	0.00	1.84	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	28.54	4.08	8.15	5.71	2.45	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	16.24	4.16	6.66	3.33	1.25	0.21	0.83	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	15.69	5.61	5.89	3.36	1.12	0.28	1.68	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	9.27	4.12	6.18	6.18	1.03	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	23.22	2.90	6.68	3.19	0.58	0.00	0.29	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	16.14	4.19	6.58	3.59	0.30	0.00	0.30	0.30
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	18.81	4.98	8.85	3.32	0.55	0.55	0.55	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	22.98	6.72	10.25	3.89	1.41	0.00	0.71	0.35
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	19.55	4.79	5.16	5.16	1.84	0.00	1.48	0.37
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	11.51	9.21	0.00	3.45	3.45	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	20.34	8.83	5.76	3.07	0.38	0.00	0.77	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	22.65	4.53	3.40	2.83	1.70	0.00	0.57	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	22.15	5.74	6.56	3.28	1.64	0.82	0.82	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	27.11	7.68	7.68	5.87	2.26	0.00	2.26	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	20.11	4.31	5.03	3.59	0.72	0.00	2.87	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	32.12	2.99	10.46	5.23	1.49	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	21.55	5.20	7.80	3.34	2.23	0.37	0.74	0.37
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	20.25	4.74	4.74	1.72	0.43	0.00	0.86	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	19.69	8.56	9.42	2.57	0.86	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	26.65	4.66	5.33	7.00	1.67	0.00	1.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	18.70	10.86	7.84	1.81	0.60	0.60	1.81	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	20.62	5.69	9.95	4.98	2.13	0.71	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	19.59	7.91	8.25	4.81	0.34	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	18.25	6.44	2.68	3.76	1.07	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	20.87	7.41	15.49	4.71	0.00	0.00	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	20.00	5.93	8.15	4.07	1.11	0.00	0.74	0.37
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	8.14	11.63	2.33	5.81	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	17.98	5.29	10.58	3.17	1.06	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	28.81	5.60	10.40	2.80	0.80	0.00	0.40	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	12.36	4.36	5.81	2.91	0.73	0.00	0.73	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	12.26	4.60	11.50	3.83	3.07	0.77	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	11.84	7.40	5.43	3.95	1.97	0.00	0.49	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	7.53	6.59	5.65	0.94	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	12.57	5.53	7.04	5.53	0.00	0.00	1.01	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	20.73	5.86	8.56	4.96	1.35	0.45	1.35	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	18.93	5.16	1.72	1.72	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	16.92	5.79	7.57	2.67	1.34	0.00	0.45	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	13.29	3.52	8.21	2.35	0.78	0.39	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	15.17	6.60	3.30	1.98	0.66	0.66	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	20.24	4.15	7.78	3.63	0.52	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	12.25	3.50	4.38	0.88	0.88	0.44	0.44	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	14.54	3.35	2.80	1.68	1.12	0.00	0.56	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	18.99	3.09	6.18	3.53	0.88	0.00	0.44	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	20.06	3.09	6.56	3.86	1.16	0.39	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	11.14	4.05	1.52	1.52	1.01	0.00	0.51	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	12.50	4.33	9.13	4.33	0.48	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	27.03	3.98	9.94	3.58	0.80	0.00	0.80	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	19.44	8.51	1.82	2.43	2.43	0.61	0.61	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	20.06	4.15	2.08	1.38	0.69	0.00	0.69	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	24.70	4.56	7.60	5.32	1.14	0.38	0.76	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	24.79	5.68	4.13	1.03	0.52	0.00	2.07	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	23.58	4.23	5.44	3.63	1.81	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	23.77	6.02	7.29	7.29	0.95	0.00	1.58	0.63
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	21.86	4.80	6.93	4.26	1.07	0.00	1.07	1.60
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	21.26	7.47	4.02	3.45	0.57	0.57	1.15	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	28.80	4.11	9.26	4.63	1.54	0.51	1.03	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	40.32	0.71	4.95	3.54	0.71	0.00	0.71	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	36.32	7.38	5.67	1.13	2.27	0.57	1.13	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	32.45	6.66	9.15	9.15	0.83	0.00	1.66	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	36.80	3.13	5.48	3.92	3.13	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	35.49	2.92	5.85	4.18	1.25	0.00	0.84	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	35.31	3.25	10.69	6.97	1.39	0.00	1.86	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	35.46	3.35	5.35	6.69	2.01	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	48.65	4.28	8.55	6.95	0.00	0.00	2.14	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	42.03	3.23	13.74	5.66	1.21	0.40	1.62	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	27.53	5.51	7.34	11.93	0.92	0.00	3.67	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	32.01	5.33	8.89	9.78	3.56	0.00	1.78	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	41.60	6.27	17.10	7.98	0.57	0.00	0.57	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	32.21	0.77	10.74	6.14	2.30	0.77	4.60	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	37.21	4.38	9.30	8.21	1.09	0.00	2.74	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	44.54	1.78	13.36	8.02	1.78	0.45	0.89	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	43.67	3.64	17.68	6.76	0.78	0.00	0.52	0.26
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	40.45	5.97	7.29	2.65	1.33	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	37.41	12.47	4.16	8.31	4.16	0.00	6.24	0.00
Macrophage - monocyte derived, donor1	11232-116C8	31.45	0.46	6.84	2.28	0.68	0.00	0.00	0.00
Macrophage - monocyte derived, donor2	11313-117C8	103.13	1.47	12.85	3.85	1.47	0.00	0.00	0.00
Macrophage - monocyte derived, donor3	11389-118C3	77.86	1.31	14.68	4.98	1.44	0.00	0.52	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	9.03	1.06	7.43	5.84	1.06	0.00	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	17.75	0.48	7.13	6.50	0.48	0.00	0.79	0.00
Mallassez-derived cells, donor3	11930-125I4	18.21	2.50	7.09	4.17	1.67	0.00	0.00	0.00
Mammary Epithelial Cell, donor1	11273-116H4	8.97	20.53	7.07	3.59	0.30	0.30	0.20	0.30
Mammary Epithelial Cell, donor2	11350-117G9	17.95	13.61	7.24	8.40	0.58	0.29	0.00	0.29
Mammary Epithelial Cell, donor3	11422-118F9	18.21	15.46	14.97	9.48	1.00	0.00	0.25	0.00
Mast cell - stimulated, donor1	11487-119E2	16.95	3.39	1.36	0.00	0.00	0.00	0.00	0.00
Mast cell, donor1	11563-120D6	53.85	13.09	9.52	6.27	0.87	0.11	0.87	0.00
Mast cell, donor2	11565-120D8	28.23	170.58	9.81	5.94	0.30	2.08	2.08	1.19
Mast cell, donor3	11566-120D9	41.20	125.62	15.08	6.30	0.68	0.68	1.58	0.00
Mast cell, donor4	11567-120E1	31.73	165.59	8.33	2.48	0.35	1.60	1.95	0.18
Mast cell, expanded and stimulated, donor5	11940-126A5	26.06	14.64	4.99	4.21	0.89	0.11	0.67	0.11
Mast cell, expanded and stimulated, donor8	11942-126A7	35.02	13.42	2.33	3.50	1.75	0.00	1.17	0.00
Mast cell, expanded, donor5	11939-126A4	67.23	6.31	13.77	6.77	1.84	0.00	1.84	0.00
Mast cell, expanded, donor8	11941-126A6	39.67	47.87	7.53	4.35	1.17	0.17	1.84	0.17
Melanocyte - dark, donor1	11502-119F8	15.82	15.72	5.77	3.78	0.60	0.10	0.00	0.30
Melanocyte - dark, donor2	11582-120F7	19.73	23.88	3.46	4.50	0.69	0.69	0.69	0.35
Melanocyte - dark, donor3	11663-122F7	38.61	7.10	17.75	11.08	2.25	0.00	0.14	0.00
Melanocyte - light, donor1	11274-116H5	31.26	9.40	15.75	9.40	3.53	0.24	0.71	0.00
Melanocyte - light, donor2	11351-117H1	22.52	15.01	4.78	2.73	0.00	0.00	0.68	0.00
Melanocyte - light, donor3	11423-118G1	38.16	4.34	13.01	11.27	0.00	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	34.15	7.81	16.14	10.62	1.15	0.00	0.52	0.00
Melanocyte, donor2 (MC+2)	12739-135I3	29.05	4.03	6.99	8.61	1.34	0.00	0.27	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	16.87	19.82	5.09	5.89	1.07	0.00	0.54	0.00
Meningeal Cells, donor1	11493-119E8	40.82	15.26	8.93	9.30	0.62	0.62	0.25	0.25
Meningeal Cells, donor2	11573-120E7	18.93	11.44	4.40	9.68	0.88	0.88	0.44	0.88
Meningeal Cells, donor3	11654-122E7	41.97	10.92	10.19	8.64	0.41	0.49	0.00	0.33
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	18.54	30.80	7.70	5.13	0.86	1.71	0.00	1.14
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	3.52	1.21	1.51	0.91	0.30	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	22.34	32.85	10.51	7.88	1.31	1.31	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	31.40	11.77	14.39	7.85	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	30.14	9.33	10.76	7.89	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	12.07	2.54	2.75	1.69	0.42	0.21	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	10.05	2.01	6.03	6.03	0.00	0.00	0.50	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	49.22	18.90	13.19	14.28	1.10	0.88	0.00	1.54
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	39.45	37.99	13.88	21.19	0.00	0.73	1.46	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	46.24	23.73	13.50	17.39	0.82	1.84	1.02	0.82
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	26.87	18.84	4.29	4.16	1.80	0.28	0.14	0.55
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	70.63	63.19	11.15	8.55	1.86	2.60	0.00	1.49
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	42.10	27.76	6.84	4.21	0.53	1.84	0.13	0.79
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	64.39	25.82	14.24	9.50	1.19	0.59	0.59	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	53.72	46.71	7.01	7.01	2.34	2.34	2.34	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	31.38	11.53	13.45	15.37	0.64	0.00	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	21.98	5.32	17.37	6.03	0.00	0.00	0.00	0.35
Mesenchymal stem cells - hepatic, donor0	11218-116B3	27.83	31.59	6.88	5.94	0.31	0.94	0.31	0.31
Mesenchymal stem cells - umbilical, donor0	11214-116A8	37.01	11.61	8.71	15.97	2.18	0.00	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	13.26	4.51	5.57	1.59	1.59	0.00	0.00	0.00
Mesothelial Cells, donor2	12156-128G5	13.01	8.51	5.00	4.00	2.00	0.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	16.04	3.40	6.43	3.25	1.16	0.00	0.43	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	141.78	8.10	9.45	4.05	4.05	0.00	0.00	1.35
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	60.58	5.91	9.60	3.94	1.72	0.00	0.74	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	67.14	16.49	4.71	2.94	0.59	0.00	0.00	0.29
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	100.26	17.29	6.91	3.46	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	40.60	4.34	6.51	4.34	1.24	0.00	0.31	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	55.80	12.24	6.43	3.32	1.24	0.00	0.62	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	67.17	6.95	2.32	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	49.05	7.26	6.51	3.25	2.00	0.00	1.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	60.98	12.57	4.65	3.26	0.93	0.00	0.00	0.93
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	38.93	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	55.88	9.55	9.14	4.67	0.81	0.00	0.20	0.20
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	55.83	15.05	4.36	3.17	0.40	0.40	0.00	0.40
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	51.31	0.00	0.00	34.21	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	39.82	6.19	3.54	0.88	0.88	0.00	0.88	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	64.21	11.78	3.80	1.90	1.14	0.00	0.76	0.38
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	57.90	6.58	2.63	2.63	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	44.35	3.18	7.43	4.03	1.49	0.21	0.64	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	31.31	11.97	3.68	1.84	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	47.69	4.47	5.66	2.98	0.89	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	35.21	11.74	5.03	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	33.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	42.65	3.01	4.27	3.26	0.75	0.00	0.50	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	55.61	12.60	4.52	3.09	0.95	0.00	0.48	0.48
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	55.84	3.87	2.21	3.32	0.55	0.55	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	37.99	5.76	6.45	3.22	0.69	0.00	0.46	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	52.80	10.94	4.84	2.94	1.68	0.21	0.21	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	59.11	5.91	6.73	5.10	1.22	0.00	1.02	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	43.12	5.79	6.22	3.22	0.64	0.00	0.21	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	56.24	14.45	6.45	2.45	0.44	0.22	0.00	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	10.32	0.00	10.32	10.32	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	42.71	4.16	3.94	4.16	1.31	0.22	0.22	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	63.88	9.13	4.56	2.53	2.03	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	76.22	1.66	4.97	3.31	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	39.41	4.08	3.53	4.35	0.82	0.00	0.54	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	62.35	10.88	3.82	4.41	0.29	0.00	0.59	0.29
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	63.24	3.27	3.27	2.18	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	48.06	3.36	5.29	6.25	1.44	0.00	0.48	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	55.63	12.41	3.60	2.80	0.40	0.00	0.00	0.80
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	39.77	2.74	4.11	4.11	1.37	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	56.57	8.01	6.51	6.01	0.50	0.00	1.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	53.89	0.00	0.00	26.95	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	36.69	8.15	8.15	4.08	2.04	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	54.30	3.94	5.26	4.38	1.75	0.44	1.31	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	43.04	6.62	8.83	0.00	0.00	0.00	0.00	1.10
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	35.86	3.20	6.40	1.92	0.64	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	50.58	4.21	4.71	3.72	1.24	0.00	0.74	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	35.49	7.65	7.65	4.18	2.09	0.70	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	39.78	8.84	15.47	6.63	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	47.18	5.47	8.55	5.13	2.05	0.00	0.68	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	44.20	7.88	9.63	2.19	1.31	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	40.48	1.42	8.88	3.91	1.07	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	46.29	3.93	10.10	1.68	1.40	0.00	0.84	0.28
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	52.78	9.56	4.99	3.33	0.42	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	48.95	1.17	15.15	2.91	1.75	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	50.98	1.81	6.64	2.11	3.02	0.00	0.60	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	53.01	11.69	6.26	2.50	2.50	0.00	0.42	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	57.75	0.00	14.44	7.22	7.22	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	44.33	3.69	6.46	0.92	0.92	0.00	0.92	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	58.62	7.40	8.54	2.28	2.85	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	59.14	2.76	12.16	4.01	3.04	0.14	0.55	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	54.16	5.96	12.18	7.52	2.07	0.26	1.55	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	63.06	9.44	7.29	4.72	1.72	0.43	0.43	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	43.19	2.54	8.26	3.18	0.64	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	40.83	3.47	6.41	3.47	1.07	0.00	0.00	0.27
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	73.04	4.49	13.47	5.99	6.29	0.00	1.20	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	55.94	1.84	9.89	4.38	1.13	0.00	0.14	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	52.55	6.69	13.06	5.10	2.23	0.00	1.59	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	59.93	10.39	9.73	5.09	2.43	0.22	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	51.19	3.03	11.76	3.03	2.65	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	41.76	4.55	8.24	4.26	3.41	0.00	0.85	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	69.07	6.39	12.29	5.65	2.95	0.00	1.47	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	40.40	3.26	7.17	6.52	2.61	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	53.51	6.47	8.82	6.17	2.35	0.00	0.29	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	79.00	8.94	13.26	5.77	3.46	0.00	1.15	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	91.50	4.95	13.60	1.24	3.30	0.00	1.24	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	52.71	10.72	12.51	2.98	2.68	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	3.77	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	8.91	0.00	3.56	3.56	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	12.81	0.99	4.60	2.30	1.64	0.00	0.99	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	44.18	0.00	4.21	4.21	1.05	0.00	1.05	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	7.71	2.77	1.98	0.20	0.79	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	20.49	5.59	1.86	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	10.14	1.13	2.63	0.75	0.75	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	37.29	3.73	4.79	0.80	0.27	0.27	0.80	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	5.88	0.23	1.13	0.23	0.45	0.00	0.11	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	20.63	2.21	5.89	2.21	1.47	0.00	0.74	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	8.06	0.73	4.40	1.10	0.37	0.00	0.73	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	24.89	0.00	4.67	0.00	1.56	0.00	1.56	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	3.21	1.60	1.07	0.00	0.53	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	3.86	0.00	0.00	0.00	3.86	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	7.07	1.01	3.03	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	18.13	3.37	5.48	1.69	0.84	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	4.09	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	3.18	1.91	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	3.24	2.43	0.81	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	10.57	1.51	1.51	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	17.13	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	16.31	29.36	3.26	0.00	3.26	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	23.76	14.26	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	12.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	8.62	0.43	4.52	4.09	0.86	0.00	0.22	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	4.18	0.52	1.05	0.00	0.00	0.00	0.52	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	12.01	0.00	6.01	8.68	2.67	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	9.18	1.25	5.84	12.52	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	7.23	0.76	3.80	3.80	0.76	0.00	0.76	0.00
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	17.55	0.00	6.38	9.58	1.60	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	4.76	1.36	4.08	3.40	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	1.84	0.00	1.84	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	5.44	3.77	5.44	7.12	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	8.37	2.32	5.11	8.14	1.86	0.00	0.23	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	4.59	1.35	2.97	5.40	0.54	0.00	0.54	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	4.84	0.63	3.78	2.31	0.21	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	7.94	0.99	6.45	5.46	1.99	0.00	0.99	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	3.52	1.89	1.62	0.54	0.27	0.00	0.27	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	6.35	3.17	4.76	2.95	0.45	0.23	0.45	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	4.74	1.96	2.61	1.80	0.49	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	6.74	2.37	2.92	2.55	0.55	0.00	0.18	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	10.61	1.06	3.18	6.90	0.53	0.00	1.06	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	3.60	3.00	4.80	4.20	0.60	0.60	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	1.31	1.97	0.98	0.66	1.31	0.00	0.33	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	5.85	4.23	2.60	3.74	0.65	0.00	0.00	0.16
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	12.88	4.41	3.00	3.17	1.06	0.18	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	9.14	0.70	5.63	6.33	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	6.90	2.30	3.22	5.06	0.46	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	8.03	2.89	3.86	4.50	1.29	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	3.10	2.41	2.07	1.03	1.38	0.34	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	0.00	2.53	0.00	5.06	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	7.13	3.12	2.45	2.90	0.00	0.00	0.22	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	9.31	2.12	4.66	8.89	0.00	0.00	0.85	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	4.51	2.61	2.14	2.85	0.95	0.00	0.00	0.24
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	8.58	3.00	3.00	6.44	0.00	0.00	0.43	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	3.67	3.33	2.00	2.67	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	7.21	0.00	3.16	1.80	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	5.16	1.59	2.78	2.78	0.40	0.00	0.40	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	8.36	6.50	5.57	4.64	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	4.54	4.16	4.92	2.65	0.76	0.00	0.38	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	4.89	2.61	2.28	6.52	0.33	0.00	0.65	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	3.92	5.23	4.36	3.05	0.87	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	7.24	1.81	3.17	3.62	0.90	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	4.41	0.00	3.53	9.70	0.00	0.00	0.88	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	10.64	4.65	6.65	5.98	0.00	0.00	0.66	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	4.46	5.46	3.47	4.46	0.50	0.00	0.50	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	4.21	2.30	3.45	3.45	0.77	0.38	0.00	0.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	4.54	3.33	5.14	2.42	0.30	0.00	0.30	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	6.85	1.33	2.87	1.99	0.44	0.00	0.22	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	6.10	7.45	2.71	3.39	0.00	0.00	0.68	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	5.11	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	4.88	6.71	3.66	3.66	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	3.46	1.89	4.09	3.78	0.63	0.31	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	2.72	2.72	4.54	2.42	0.30	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	5.54	4.75	8.70	3.16	0.79	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	1.13	4.53	0.00	1.13	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	0.00	5.06	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	23.48	8.20	7.83	5.22	1.37	0.12	0.37	0.25
Myoblast, donor2	11322-117D8	15.15	25.32	5.95	5.18	0.58	0.00	0.96	0.77
Myoblast, donor3	11398-118D3	24.22	10.09	8.58	6.56	2.19	0.00	0.34	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	72.09	36.78	24.22	14.45	1.02	0.44	0.73	0.29
Natural Killer Cells, donor1	11230-116C6	24.29	335.50	6.15	4.61	0.31	9.23	0.62	2.77
Natural Killer Cells, donor2	11311-117C6	22.01	316.33	8.75	4.52	0.00	6.33	2.11	1.81
Natural Killer Cells, donor3	11387-118C1	27.42	340.13	7.36	3.68	0.55	6.07	1.10	2.94
Neural stem cells, donor1	11275-116H6	17.42	2.54	5.44	4.36	1.09	0.00	1.09	0.00
Neural stem cells, donor2	11352-117H2	17.33	1.93	5.78	1.93	1.93	0.00	0.00	0.00
Neurons, donor1	11494-119E9	26.17	4.55	9.10	6.83	2.28	0.00	1.14	0.00
Neurons, donor2	11574-120E8	13.87	2.20	8.81	4.40	0.44	0.66	0.66	0.00
Neurons, donor3	11655-122E8	19.73	2.47	3.29	4.93	1.64	1.64	0.82	0.00
Neutrophils, donor1	11233-116C9	88.16	81.66	11.14	3.71	0.00	0.93	0.93	0.93
Neutrophils, donor2	11314-117C9	78.27	118.85	17.39	2.90	2.90	11.60	0.00	0.00
Neutrophils, donor3	11390-118C4	112.40	89.18	15.88	5.50	1.22	1.22	2.44	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	6.29	33.60	3.68	0.59	0.47	1.66	0.36	0.59
Nucleus Pulposus Cell, donor2	11409-118E5	8.79	70.66	2.28	1.30	0.33	3.58	0.98	2.60
Nucleus Pulposus Cell, donor3	11462-119B4	5.41	47.73	2.01	2.21	0.80	1.20	0.00	1.40
Olfactory epithelial cells, donor1	11933-125I7	6.88	1.38	2.34	0.96	0.28	0.00	0.00	0.00
Olfactory epithelial cells, donor2	11934-125I8	8.25	0.29	3.76	3.33	1.01	0.00	0.58	0.00
Olfactory epithelial cells, donor3	11935-125I9	7.60	1.14	4.31	3.29	0.45	0.11	0.11	0.00
Olfactory epithelial cells, donor4	11936-126A1	7.40	1.36	4.48	2.82	0.29	0.00	0.29	0.00
Oligodendrocyte - precursors, donor1	11496-119F2	31.29	15.65	10.83	12.64	1.20	1.20	0.00	0.60
Osteoblast - differentiated, donor1	11276-116H7	21.06	33.18	7.87	3.62	0.00	0.85	1.28	1.28
Osteoblast - differentiated, donor2	11353-117H3	17.15	33.15	4.57	3.43	0.00	2.29	0.00	1.14
Osteoblast - differentiated, donor3	11425-118G3	11.17	67.66	4.34	2.48	0.62	0.00	1.24	1.24
Osteoblast, donor1	11277-116H8	8.40	2.15	5.08	4.50	0.59	0.00	0.00	0.00
Osteoblast, donor2	11354-117H4	23.18	0.70	11.24	4.21	0.00	0.00	0.00	0.00
Osteoblast, donor3	11426-118G4	20.62	5.33	9.95	7.64	1.78	0.18	0.18	0.00
Pancreatic stromal cells, donor1	11249-116E7	9.01	0.51	5.22	2.36	0.67	0.00	0.00	0.08
Pericytes, donor1	11491-119E6	11.02	34.94	4.23	3.67	0.22	3.56	0.11	1.89
Pericytes, donor2	11571-120E5	21.50	51.39	4.98	7.92	0.23	6.34	0.45	1.13
Pericytes, donor3	11652-122E5	39.67	28.89	14.44	10.17	1.22	0.81	0.81	0.61
Perineurial Cells, donor1	11499-119F5	12.55	10.17	7.23	6.22	0.11	0.23	0.00	0.34
Perineurial Cells, donor2	11579-120F4	20.98	21.62	6.44	4.97	1.20	0.55	0.09	0.55
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	82.55	264.87	9.88	3.51	0.96	6.69	0.64	3.19
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	71.01	201.28	12.98	4.65	0.73	3.67	2.20	1.71
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	47.62	283.55	9.58	4.53	1.04	5.95	1.16	2.33
Placental Epithelial Cells, donor1	11278-116H9	76.05	16.02	15.07	14.59	1.67	0.00	1.20	0.00
Placental Epithelial Cells, donor2	11355-117H5	82.06	32.16	14.42	16.63	4.44	0.00	1.11	1.11
Placental Epithelial Cells, donor3	11427-118G5	106.80	34.75	29.06	25.13	2.16	0.59	1.57	0.39
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	16.77	2.85	8.86	7.28	0.32	0.00	1.27	0.00
Preadipocyte - breast, donor1	11467-119B9	7.88	3.38	2.81	1.69	0.94	0.00	0.38	0.19
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	18.80	0.78	5.35	2.61	0.39	0.13	0.13	0.00
Preadipocyte - breast, donor2	11328-117E5	19.59	2.03	7.66	4.73	0.45	0.00	0.45	0.00
Preadipocyte - omental, donor1	11468-119C1	4.80	2.24	2.88	2.02	0.43	0.11	0.11	0.00
Preadipocyte - omental, donor2	11329-117E6	24.88	3.93	9.17	4.80	1.31	0.00	0.44	0.00
Preadipocyte - omental, donor3	11403-118D8	9.60	1.29	6.30	4.73	1.43	0.00	0.43	0.00
Preadipocyte - perirenal, donor1	11469-119C2	24.61	13.78	4.92	3.94	2.95	0.98	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	51.29	3.07	15.36	7.06	1.54	0.00	0.31	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	36.48	0.89	10.09	12.04	1.06	0.00	1.06	0.00
Preadipocyte - subcutaneous, donor3	11428-118G6	24.01	2.55	9.20	5.45	1.02	0.00	0.68	0.00
Preadipocyte - visceral, donor1	11280-116I2	23.29	0.84	9.31	3.73	0.75	0.00	0.37	0.00
Preadipocyte - visceral, donor2	11357-117H7	33.13	0.00	7.36	6.90	3.22	0.00	0.46	0.00
Preadipocyte - visceral, donor3	11429-118G7	25.08	1.15	7.52	6.06	1.67	0.00	0.73	0.00
Prostate Epithelial Cells (polarized), donor1	11253-116F2	10.26	4.07	3.02	2.87	0.00	0.00	1.21	0.15
Prostate Epithelial Cells, donor2	11331-117E8	12.59	2.98	5.01	5.42	1.90	0.14	0.41	0.00
Prostate Epithelial Cells, donor3	11404-118D9	0.61	3.98	0.86	0.55	0.00	0.06	0.06	0.06
Prostate Stromal Cells, donor1	11254-116F3	22.89	1.14	7.29	4.56	1.14	0.00	0.91	0.00
Prostate Stromal Cells, donor2	11332-117E9	23.85	1.08	6.63	7.53	0.90	0.00	0.72	0.00
Prostate Stromal Cells, donor3	11405-118E1	20.33	0.94	6.57	5.32	0.73	0.00	0.52	0.00
Renal Cortical Epithelial Cells, donor1	11516-119H4	10.95	3.28	5.84	7.30	1.46	0.00	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	7.90	1.94	3.19	3.95	0.55	0.00	0.07	0.00
Renal Epithelial Cells, donor1	11517-119H5	24.35	11.16	16.23	17.25	1.01	0.00	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	24.90	14.94	2.85	7.82	1.42	0.71	0.71	0.00
Renal Epithelial Cells, donor3	11678-122H4	8.89	8.36	2.75	3.49	0.64	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor1	11514-119H2	47.66	21.79	4.77	14.30	0.68	0.00	0.68	0.68
Renal Glomerular Endothelial Cells, donor2	11594-120H1	37.06	6.60	6.47	11.05	1.48	0.00	0.67	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	35.08	14.43	8.44	11.10	2.00	0.89	1.11	0.44
Renal Glomerular Endothelial Cells, donor4	11783-124B1	37.26	9.32	9.32	11.98	2.66	0.67	1.33	0.00
Renal Mesangial Cells, donor1	11518-119H6	31.25	14.97	10.78	8.14	0.88	0.66	0.00	1.10
Renal Mesangial Cells, donor2	11598-120H5	15.05	19.44	9.40	12.54	0.00	0.00	0.00	0.63
Renal Mesangial Cells, donor3	11679-122H5	15.81	11.65	8.04	9.15	0.28	0.00	0.28	0.28
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	19.06	7.25	7.78	8.32	1.07	0.00	0.54	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	9.28	3.37	5.90	6.75	0.42	0.00	0.84	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	21.98	9.84	9.84	14.85	0.19	0.00	0.39	0.39
Retinal Pigment Epithelial Cells, donor0	11215-116A9	6.48	0.78	3.89	5.44	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	8.24	11.37	2.27	3.98	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	13.38	4.12	10.29	10.29	0.00	0.00	1.03	1.03
Retinal Pigment Epithelial Cells, donor3	11689-122I6	2.26	7.28	0.75	1.76	0.00	0.00	0.00	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	21.92	49.18	7.35	2.27	0.27	1.20	0.80	1.20
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	32.16	7.15	6.25	1.79	0.89	0.00	1.79	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	24.77	5.50	4.40	3.30	1.65	0.00	1.65	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	22.04	5.22	10.44	5.80	0.00	0.00	0.00	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	36.41	1.82	5.59	3.90	0.00	0.13	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	49.95	2.48	15.19	7.65	0.30	0.00	1.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	64.13	4.46	15.17	5.24	0.22	0.11	0.56	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	38.21	1.49	10.67	6.70	0.25	0.12	0.74	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	58.97	3.85	17.13	8.39	0.35	0.12	0.93	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	60.56	3.70	15.95	8.55	0.00	0.00	0.92	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	39.29	2.46	10.82	7.94	1.10	0.00	0.41	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	47.05	2.42	14.37	7.56	0.15	0.15	0.45	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	53.04	3.94	19.17	6.09	0.36	0.18	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	46.91	3.73	8.18	8.32	0.57	0.00	0.86	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	50.55	3.65	17.06	8.26	0.43	0.00	1.72	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	52.66	3.54	10.84	5.75	0.89	0.00	1.55	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	30.40	1.15	8.60	7.84	0.57	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	48.91	2.24	12.67	8.20	0.19	0.00	0.56	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	61.82	4.32	13.53	6.20	0.00	0.00	0.75	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	40.87	0.80	10.09	5.84	1.06	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	50.71	2.92	15.28	6.23	0.58	0.10	1.17	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	57.67	4.96	11.46	8.40	0.38	0.00	0.38	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	44.11	2.24	7.90	6.83	0.32	0.11	0.43	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	44.57	2.80	10.93	7.85	1.40	0.00	0.56	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	59.13	3.08	13.84	5.64	0.85	0.00	0.68	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	38.11	2.19	10.03	5.65	0.36	0.00	0.00	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	55.55	3.07	16.31	9.32	0.74	0.00	0.74	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	55.61	4.16	17.46	7.25	0.54	0.00	0.40	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	45.05	2.59	5.43	6.13	0.00	0.00	0.71	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	48.61	2.98	16.47	8.73	0.79	0.00	1.59	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	58.70	3.51	18.47	7.72	0.47	0.23	0.47	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	47.07	2.49	10.37	7.46	0.41	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	54.64	3.76	11.72	7.30	0.00	0.00	0.88	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	54.52	3.55	12.74	7.94	0.84	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	53.16	1.75	9.56	9.69	1.21	0.00	0.94	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	40.87	2.55	13.28	7.49	1.02	0.17	0.17	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	63.62	3.28	14.27	9.06	0.77	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	50.03	0.69	12.04	9.11	0.69	0.00	0.34	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	54.04	2.47	15.36	8.50	1.23	0.00	0.69	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	56.31	2.13	14.12	9.36	0.33	0.16	0.49	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	43.12	3.07	10.23	8.35	0.68	0.00	0.68	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	50.60	2.52	14.50	7.69	0.74	0.00	0.89	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	54.64	5.33	13.33	8.26	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	30.28	5.67	7.60	9.40	0.28	0.14	0.41	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	61.43	6.67	20.95	6.90	0.71	0.48	0.71	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	76.99	8.06	22.17	10.48	0.20	0.00	0.20	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	53.59	6.97	13.18	8.76	0.57	0.09	1.13	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	45.42	8.38	14.32	9.78	0.70	0.00	1.05	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	47.45	10.28	9.07	6.95	0.60	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	69.27	7.22	12.73	7.22	0.37	0.12	2.33	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	57.49	10.63	12.37	4.80	0.58	0.44	0.44	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	41.98	9.73	21.90	9.13	1.83	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	62.69	3.92	15.97	9.04	1.51	0.00	1.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	69.67	9.27	21.04	9.27	1.13	0.23	2.04	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	65.90	9.59	20.07	9.29	0.90	0.00	1.80	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	46.52	6.73	6.38	4.25	0.59	0.35	3.31	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	63.39	11.74	20.49	8.54	0.21	0.00	7.68	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	69.71	11.42	21.64	7.81	0.00	0.00	3.61	0.00
Schwann Cells, donor1	11498-119F4	17.11	14.29	9.78	10.91	0.00	0.94	0.94	0.19
Schwann Cells, donor2	11578-120F3	20.41	3.40	10.21	3.40	0.00	0.00	3.40	0.00
Schwann Cells, donor3	11659-122F3	21.91	15.99	10.73	12.27	0.88	0.22	0.66	0.44
Sebocyte, donor1	11220-116B5	20.27	3.83	9.86	5.48	0.00	0.00	0.00	0.00
Sebocyte, donor2	11301-117B5	16.08	7.35	10.57	7.35	0.00	0.00	0.92	0.00
Sebocyte, donor3	11378-118B1	12.37	13.19	8.24	6.18	0.62	0.00	0.41	0.00
Sertoli Cells, donor1	11255-116F4	14.91	0.00	9.94	0.00	3.31	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	2.82	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	8.27	1.94	4.22	2.38	0.70	0.00	0.35	0.00
Skeletal Muscle Cells, donor2	11358-117H8	7.95	5.78	1.45	0.72	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	32.61	3.34	19.23	19.23	1.67	0.00	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	21.05	10.53	8.01	8.95	0.47	0.00	0.16	0.31
Skeletal Muscle Cells, donor5	11455-119A6	16.50	11.00	4.61	8.92	0.30	0.15	0.15	0.00
Skeletal Muscle Cells, donor6	11459-119B1	26.47	8.93	8.62	12.31	0.31	0.15	1.08	0.15
Skeletal Muscle Satellite Cells, donor1	11240-116D7	12.47	20.41	4.41	3.91	0.50	0.38	0.38	0.25
Skeletal Muscle Satellite Cells, donor2	11321-117D7	19.83	18.26	5.99	6.56	0.71	0.29	0.43	0.29
Skeletal Muscle Satellite Cells, donor3	11397-118D2	26.49	13.10	12.50	10.81	1.09	0.30	0.50	0.10
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	21.06	3.12	6.49	5.06	0.42	0.17	0.08	0.17
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	20.27	0.72	11.58	8.69	0.72	0.00	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	14.31	3.58	4.54	4.27	0.96	0.00	0.96	0.00
Skin - palm, donor1	10286-104F7	2.69	64.47	2.69	0.00	0.00	2.69	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	15.28	7.35	5.62	7.21	1.30	0.14	0.58	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	9.00	5.73	2.45	4.09	0.82	0.00	0.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	18.70	10.91	6.75	7.79	1.04	0.13	1.04	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	6.26	7.37	2.50	2.92	0.70	0.00	0.83	0.14
Small Airway Epithelial Cells, donor2	11334-117F2	6.05	5.91	4.08	5.34	0.56	0.00	0.14	0.28
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	14.38	14.17	7.61	3.59	1.27	0.00	0.00	0.00
Small Airway Epithelial Cells, donor3	11406-118E2	2.85	5.25	2.17	2.25	0.37	0.07	0.07	0.00
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	11.73	0.62	5.86	6.17	0.93	0.00	0.62	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	7.34	0.22	1.33	1.78	1.11	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	14.11	0.00	17.63	7.64	1.76	0.00	0.59	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	32.26	7.96	13.48	9.28	1.55	0.00	0.44	0.22
Smooth Muscle Cells - Aortic, donor2	11360-117I1	39.38	1.18	20.08	6.69	3.15	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	23.18	0.77	11.59	7.73	1.55	0.00	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	24.02	27.02	4.00	3.00	0.00	3.00	3.00	1.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	19.43	1.86	11.18	7.32	2.00	0.00	0.40	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	18.62	0.22	7.76	6.21	1.33	0.00	0.44	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	7.30	0.77	4.10	4.61	1.54	0.00	0.38	0.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	27.35	11.72	10.42	5.54	0.33	0.33	0.65	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	27.17	20.38	11.22	7.68	1.48	0.59	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	40.86	19.65	10.82	6.26	1.00	0.28	0.14	0.43
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	47.66	11.22	13.99	12.69	1.14	0.00	0.16	0.65
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	9.13	28.62	1.83	2.44	0.91	1.52	0.00	1.22
Smooth Muscle Cells - Carotid, donor1	11285-116I7	15.41	0.51	7.58	2.78	3.28	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	36.72	6.12	18.36	18.36	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	10.49	1.43	6.68	4.77	3.34	0.00	0.95	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	28.02	4.87	6.78	5.16	0.44	0.00	0.29	0.29
Smooth Muscle Cells - Colonic, donor2	11320-117D6	26.47	6.03	6.46	7.53	1.29	0.00	0.65	0.22
Smooth Muscle Cells - Colonic, donor3	11396-118D1	30.44	7.66	11.23	7.98	1.05	0.10	0.73	0.31
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	35.42	1.39	16.71	10.21	2.01	0.00	0.31	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	44.19	1.08	17.25	15.09	6.47	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	20.62	0.30	5.08	8.07	1.79	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	48.48	20.48	17.07	10.58	0.34	0.68	0.00	0.34
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	5.03	16.73	1.96	1.33	0.39	1.33	0.00	1.26
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	18.52	3.62	7.25	4.73	2.01	0.00	0.30	0.10
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	40.05	21.85	18.43	12.06	3.19	0.00	1.59	0.23
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	21.74	2.42	6.64	9.66	1.21	0.00	1.21	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	41.06	18.81	17.22	15.63	1.06	1.85	0.26	0.26
Smooth Muscle Cells - Prostate, donor1	11257-116F6	25.30	1.46	6.39	5.19	1.33	0.00	0.00	0.00
Smooth Muscle Cells - Prostate, donor2	11335-117F3	27.92	1.00	7.89	8.39	0.63	0.00	1.25	0.13
Smooth Muscle Cells - Prostate, donor3	11465-119B7	5.83	1.78	1.27	0.51	0.76	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	29.55	1.21	8.74	8.44	1.06	0.00	0.45	0.00
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	12.75	3.75	4.50	3.75	2.25	0.00	0.75	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	31.01	9.05	9.05	9.05	2.58	0.00	1.29	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	26.04	1.86	9.30	5.58	1.86	0.00	0.47	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	31.30	1.01	16.66	9.09	5.55	0.00	3.53	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	22.25	4.07	7.83	9.09	5.33	0.00	1.25	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	35.69	18.29	11.80	8.85	0.88	0.29	0.59	0.59
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	23.74	18.91	9.50	6.25	0.83	0.75	0.08	0.67
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	12.61	21.02	3.27	4.67	1.87	0.93	0.00	1.40
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	16.55	0.58	10.22	5.47	4.17	0.00	0.29	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	23.71	7.14	13.77	10.96	2.55	0.00	0.25	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	16.36	0.75	8.46	6.39	2.26	0.00	0.19	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	14.25	7.69	6.43	6.71	0.84	0.14	0.14	0.00
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	36.62	17.76	10.98	8.63	0.84	0.34	0.34	0.17
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	8.57	20.00	3.81	3.33	0.48	0.48	0.00	0.48
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	19.82	1.71	13.70	5.14	1.71	0.00	0.98	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	44.85	0.44	6.85	5.97	1.77	0.00	0.00	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	14.63	0.29	8.78	5.27	0.29	0.00	0.29	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	3.89	0.78	2.14	1.17	0.58	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	3.70	0.79	2.91	3.17	0.00	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	4.09	0.00	1.49	1.12	1.12	0.00	0.37	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	15.81	2.16	1.80	5.03	0.36	0.00	0.36	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	9.08	2.84	2.84	3.69	1.14	0.00	0.28	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	12.60	0.39	5.12	1.97	0.39	0.00	0.79	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	3.81	2.03	1.52	1.27	1.52	0.00	0.25	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	4.39	1.60	1.20	0.80	0.80	0.40	1.60	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	2.51	1.67	1.67	1.25	0.42	0.00	0.00	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	4.58	5.96	1.38	0.92	0.46	0.00	0.00	0.00
Synoviocyte, donor1	11291-117A4	17.51	0.84	3.70	1.85	0.50	0.00	0.17	0.00
Synoviocyte, donor2	11368-117I9	7.38	3.52	4.69	2.85	1.51	0.00	0.34	0.00
Synoviocyte, donor3	11440-118H9	6.93	0.89	3.80	0.45	0.89	0.00	0.00	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	30.37	35.73	12.15	8.22	0.00	1.79	0.36	2.14
Trabecular Meshwork Cells, donor2	11612-122A1	19.82	77.30	3.96	0.00	0.00	0.00	0.00	5.95
Trabecular Meshwork Cells, donor3	11693-123A1	17.83	65.06	8.34	6.71	0.46	3.24	0.00	3.01
Tracheal Epithelial Cells, donor1	11292-117A5	14.41	5.52	7.10	3.87	0.50	0.14	0.43	0.00
Tracheal Epithelial Cells, donor2	11369-118A1	22.42	10.05	12.37	8.89	1.55	0.00	0.39	0.39
Tracheal Epithelial Cells, donor3	11441-118I1	16.61	3.44	6.87	4.01	1.72	0.00	1.15	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	18.82	44.78	7.14	2.58	0.00	0.86	0.49	0.62
Urethra, donor2	10319-105A4	1.80	44.96	1.80	3.60	0.00	0.00	0.00	1.80
Urothelial Cells, donor1	11520-119H8	22.05	2.66	10.36	8.24	2.39	0.00	0.27	0.00
Urothelial Cells, donor2	11600-120H7	15.22	6.81	7.21	4.01	1.60	0.00	0.80	0.00
Urothelial Cells, donor3	11681-122H7	14.44	5.27	6.65	5.04	1.38	0.00	0.23	0.00
Urothelial cells, donor0	11216-116B1	17.16	9.58	9.36	3.79	0.67	0.67	0.00	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	273.16	189.52	23.13	9.79	7.12	1.78	1.78	1.78
Whole blood (ribopure), donor090309, donation2	12180-129A2	273.06	215.87	17.16	7.15	4.29	5.72	0.00	2.86
Whole blood (ribopure), donor090309, donation3	12181-129A3	195.09	142.38	23.96	16.43	4.79	2.05	3.42	1.37
Whole blood (ribopure), donor090325, donation1	12176-128I7	118.80	204.54	14.81	6.20	2.07	3.10	0.00	1.03
Whole blood (ribopure), donor090325, donation2	12177-128I8	122.02	150.49	11.04	4.07	2.91	5.23	0.00	2.32
Whole blood (ribopure), donor090612, donation1	12182-129A4	187.42	156.19	11.45	9.37	7.29	0.00	0.00	4.16
Whole blood (ribopure), donor090612, donation2	12183-129A5	171.63	146.85	1.84	5.51	9.18	2.75	0.00	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	194.45	130.54	22.82	10.95	4.56	2.74	8.22	0.91
Wilms' tumor cell line:G-401	10809-111A8	12.95	2.10	5.06	4.69	0.25	0.12	0.12	0.12
Wilms' tumor cell line:HFWT	10597-108E3	3.52	0.00	0.88	3.52	0.00	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	6.98	0.56	1.96	2.23	0.00	0.00	0.00	0.00
achilles tendon, donor2	10292-104G4	24.80	41.33	2.07	2.07	0.00	0.00	0.00	2.07
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	15.04	3.57	5.61	2.80	0.00	0.00	0.25	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	416.06	26.70	83.35	94.73	1.39	0.00	1.39	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	365.98	158.71	55.32	65.76	0.36	6.53	2.14	2.61
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	115.65	11.70	22.04	21.77	0.54	0.00	1.63	0.54
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	91.07	11.24	16.87	20.52	0.00	0.28	0.84	0.28
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	53.50	17.34	15.65	11.42	1.06	0.00	0.85	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	92.55	40.56	17.97	20.96	1.36	0.82	2.45	0.54
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	5.29	4.85	0.44	0.44	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	135.98	20.83	19.19	19.19	1.23	0.00	1.23	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	163.09	22.52	34.95	31.84	1.16	0.00	1.16	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	30.73	1.84	6.62	4.78	0.55	0.00	0.92	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	58.51	35.10	15.60	19.50	7.80	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	57.17	44.15	12.78	15.80	0.93	1.16	0.70	0.93
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	228.09	10.36	38.32	40.65	1.04	0.00	1.55	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	85.04	3.80	16.37	15.78	1.17	0.00	1.17	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	48.80	1.39	17.20	11.15	0.93	0.46	0.93	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	99.52	4.94	9.46	6.58	0.41	0.00	1.65	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	62.00	0.00	28.85	23.02	0.92	0.00	0.31	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	81.93	0.00	24.32	15.79	0.85	0.00	0.43	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	73.09	0.00	26.69	8.80	0.30	0.00	0.30	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	100.86	0.24	30.33	12.52	1.20	0.00	0.48	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	113.37	1.11	21.16	22.05	0.89	0.22	0.67	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	318.54	24.68	48.03	72.38	0.00	0.00	2.00	0.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	89.19	18.58	29.73	52.03	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	233.15	9.04	44.82	96.43	0.75	0.00	4.90	0.38
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	90.72	8.29	15.26	24.42	0.00	0.00	1.31	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	74.98	7.50	26.24	33.74	0.00	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	7.30	0.24	7.77	3.53	0.00	0.00	0.00	0.00
adipose tissue, adult, pool1	10010-101C1	13.65	47.00	5.43	2.02	0.47	0.62	0.62	0.47
adipose, donor1	10184-103D4	1.76	2.93	2.93	3.52	0.00	0.59	0.00	0.00
adipose, donor2	10185-103D5	2.84	0.00	0.00	4.06	0.00	0.00	0.41	0.00
adipose, donor3	10186-103D6	4.36	1.09	4.08	5.99	0.27	0.00	0.00	0.00
adipose, donor4	10187-103D7	34.67	1.73	4.33	36.40	0.87	0.00	0.87	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	3.95	3.00	6.47	17.52	0.00	0.00	0.00	0.16
adrenal gland, adult, pool1	10081-102A9	58.20	18.19	29.10	21.83	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	54.83	13.07	29.62	21.88	0.67	0.00	0.67	0.00
alveolar cell carcinoma cell line:SW 1573	10708-109H6	39.30	3.22	17.86	10.72	1.79	0.00	0.36	0.00
amniotic membrane cells, donor1	12235-129G3	19.94	12.98	12.52	9.74	0.46	0.00	0.70	0.00
amniotic membrane cells, donor2	12236-129G4	43.62	9.47	17.24	6.42	3.04	0.34	0.34	0.00
amniotic membrane cells, donor3	12237-129G5	33.00	21.51	18.27	12.37	1.18	0.88	0.29	0.29
amygdala - adult, donor10196	10167-103B5	20.16	17.79	5.93	2.37	1.19	1.19	3.56	0.00
amygdala, adult, donor10252	10151-102I7	14.19	32.24	10.95	7.30	0.81	0.20	0.20	0.00
amygdala, newborn, donor10223	10360-105E9	18.72	8.07	3.55	5.49	1.29	0.00	0.65	0.32
anaplastic carcinoma cell line:8305C	10428-106D5	2.29	8.40	1.66	0.51	0.13	0.13	0.00	0.25
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	132.37	1.99	41.92	46.77	0.22	0.00	1.54	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	9.35	18.04	2.00	2.67	0.33	1.00	0.33	0.67
aorta, adult, pool1	10052-101G7	4.12	40.99	4.51	3.14	0.00	0.59	0.20	0.78
appendix, adult	10189-103D9	33.77	105.57	8.15	8.15	0.00	1.55	1.55	0.78
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	32.33	6.88	3.78	2.75	1.03	0.00	0.34	0.34
artery, adult	10190-103E1	4.08	19.02	1.36	0.00	0.00	1.36	0.00	1.36
astrocytoma cell line:TM-31	10425-106D2	18.98	10.00	9.13	8.40	0.29	0.14	0.29	0.00
b cell line:RPMI1788	10427-106D4	8.18	1.78	4.76	3.87	0.30	0.00	0.00	0.00
basal cell carcinoma cell line:TE 354.T	10702-109G9	10.82	0.00	4.72	2.22	1.94	0.00	0.28	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	12.70	2.08	9.63	3.97	0.30	0.00	0.00	0.00
bile duct carcinoma cell line:TFK-1	10496-107C1	86.87	1.34	23.10	8.03	1.84	0.00	1.51	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	52.01	2.24	13.42	7.83	1.12	0.00	0.00	0.00
bladder, adult, pool1	10011-101C2	6.95	36.94	3.59	1.41	0.22	0.43	0.54	0.43
blood, adult, pool1	10053-101G8	124.02	155.02	13.29	11.07	6.64	2.21	2.21	2.21
bone marrow stromal cell line:StromaNKtert	10686-109F2	11.99	51.38	3.43	3.43	1.71	0.00	0.00	0.00
bone marrow, adult	10192-103E3	77.60	20.24	9.45	7.42	0.67	0.00	2.70	1.35
brain, adult, donor1	10084-102B3	15.38	21.53	5.13	6.15	1.03	4.10	0.00	0.00
brain, adult, pool1	10012-101C3	18.49	24.61	7.24	6.01	1.34	1.22	0.67	0.56
brain, fetal, pool1	10085-102B4	10.69	21.37	8.01	8.01	0.00	2.67	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	5.95	4.96	3.30	3.30	0.66	0.00	0.00	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	18.35	0.37	15.48	4.12	1.50	0.00	0.12	0.00
breast, adult, donor1	10080-102A8	17.05	84.60	5.68	5.68	0.63	0.63	0.00	1.26
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	11.69	2.54	8.13	2.92	0.76	0.13	0.13	0.00
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	4.02	5.88	3.40	2.78	0.93	0.31	0.00	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	3.91	37.30	1.38	3.22	0.46	0.23	0.69	0.23
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	26.15	0.48	6.29	2.91	0.48	0.00	0.24	0.00
carcinoid cell line:NCI-H1770	10703-109H1	13.16	0.47	10.81	6.11	0.00	0.00	0.00	0.00
carcinoid cell line:NCI-H727	10735-110B6	5.25	6.02	4.16	4.05	0.00	0.22	0.11	0.00
carcinoid cell line:SK-PN-DW	10719-109I8	14.89	0.95	6.65	5.07	0.00	0.00	0.32	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	25.55	0.00	5.59	3.46	0.53	0.00	0.80	0.00
caudate nucleus - adult, donor10196	10177-103C6	12.66	17.27	4.61	5.76	0.00	0.00	1.15	0.00
caudate nucleus, adult, donor10252	10164-103B2	17.57	31.29	5.69	4.52	0.84	0.67	0.17	0.33
caudate nucleus, adult, donor10258	10379-105H1	28.27	11.46	2.29	4.58	2.29	1.53	0.00	1.53
caudate nucleus, newborn, donor10223	10354-105E3	17.95	4.76	2.93	4.03	0.37	0.00	0.37	0.00
cerebellum - adult, donor10196	10173-103C2	5.83	8.74	8.74	2.91	0.00	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	10.46	37.58	7.90	2.56	1.07	0.85	0.64	0.43
cerebellum, adult, pool1	10083-102B2	15.87	18.63	7.93	5.17	0.69	0.69	0.34	0.34
cerebellum, newborn, donor10223	10357-105E6	9.13	29.06	2.49	1.66	0.83	2.49	0.83	0.00
cerebral meninges, adult	10188-103D8	12.35	30.51	4.54	5.04	2.02	1.26	1.01	0.25
cerebrospinal fluid, donor2	10294-104G6	7.31	7.31	2.92	2.19	0.73	0.00	1.46	0.00
cervical cancer cell line:D98-AH2	10552-107I3	13.52	0.14	10.06	3.16	0.29	0.00	0.00	0.00
cervical cancer cell line:ME-180	10553-107I4	4.64	0.66	3.65	0.99	0.33	0.00	0.00	0.00
cervix, adult, pool1	10013-101C4	8.08	55.01	2.52	0.94	0.21	1.05	0.63	0.73
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	9.34	0.42	4.04	2.23	0.70	0.00	0.14	0.00
chondrosarcoma cell line:SW 1353	10700-109G7	2.61	0.00	3.92	1.31	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	51.33	4.35	18.39	20.01	0.99	0.00	2.61	0.00
choriocarcinoma cell line:SCH	10785-110H2	50.89	3.20	23.41	19.59	1.23	0.00	0.37	0.00
choriocarcinoma cell line:T3M-3	10618-108G6	13.76	1.90	9.96	11.86	0.24	0.00	0.47	0.00
chorionic membrane cells, donor1	12238-129G6	8.55	7.69	4.84	2.85	0.28	0.57	0.00	0.00
chorionic membrane cells, donor2	12239-129G7	22.57	4.87	10.84	5.37	0.70	0.00	0.60	0.00
chorionic membrane cells, donor3	12240-129G8	8.79	11.54	2.20	4.40	0.55	0.00	0.55	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	227.21	13.13	21.21	26.25	2.02	0.00	6.06	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	174.04	22.48	35.92	37.27	0.58	0.19	2.50	0.00
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	114.89	15.42	30.62	24.50	1.69	0.00	0.63	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	65.74	7.70	21.57	35.18	0.26	0.00	0.26	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	66.27	8.95	26.61	44.99	0.00	0.00	0.24	0.24
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	76.96	14.86	20.36	38.28	0.20	0.00	0.61	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	94.81	4.42	32.98	35.92	0.00	0.29	0.29	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	81.32	21.11	16.42	22.15	1.04	0.00	0.26	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	6.40	2.29	7.54	7.54	0.23	0.00	0.23	0.00
clear cell carcinoma cell line:TEN	10636-108I6	8.50	1.04	3.82	1.91	0.35	0.00	0.17	0.00
colon carcinoma cell line:CACO-2	10513-107D9	11.17	2.01	5.31	3.84	0.18	0.00	0.00	0.00
colon carcinoma cell line:COLO-320	10420-106C6	7.60	3.42	6.46	4.56	0.38	0.00	0.00	0.00
colon, adult, donor1	10082-102B1	5.95	45.22	10.71	0.00	1.19	1.19	1.19	0.00
colon, adult, pool1	10014-101C5	17.27	54.52	7.17	2.00	0.24	0.94	0.71	0.47
colon, fetal, donor1	10070-101I7	7.42	32.14	3.09	2.47	0.62	1.24	0.00	1.85
common myeloid progenitor CMP, donor1	12130-128D6	9.17	87.09	0.00	0.00	0.00	4.58	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	25.04	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	10.62	3.82	2.55	2.55	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	23.24	2.72	2.72	2.57	0.60	0.00	0.00	0.15
cord blood derived cell line:COBL-a untreated	10449-106F8	25.81	3.10	5.08	2.82	0.42	0.00	0.14	0.00
corpus callosum, adult, pool1	10042-101F6	21.34	25.87	12.71	5.31	0.77	0.88	0.11	0.33
cruciate ligament, donor2	10295-104G7	14.59	35.66	1.62	4.05	0.00	0.81	0.00	0.81
diaphragm, fetal, donor1	10069-101I6	12.84	10.43	4.82	2.41	0.80	0.00	0.80	1.61
diencephalon, adult	10193-103E4	18.00	14.40	6.72	3.84	0.96	0.96	0.48	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	10.33	7.12	1.84	4.13	0.23	0.00	0.46	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	6.92	2.56	1.54	2.31	0.51	0.00	0.00	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	1.44	1.44	2.41	2.65	0.24	0.24	0.00	0.00
ductus deferens, adult	10196-103E7	5.48	54.82	1.99	0.00	0.50	0.50	0.50	0.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	8.64	21.60	4.32	1.44	1.44	0.00	4.32	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	19.13	36.78	5.15	2.94	0.74	1.47	0.74	0.00
dura mater, adult, donor1	10041-101F5	24.03	56.65	6.94	2.64	1.24	1.40	0.25	0.17
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	24.87	20.65	5.55	19.99	0.89	0.67	0.89	0.22
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	14.33	7.02	5.88	11.03	0.14	0.14	0.00	0.00
embryonic pancreas cell line:1B2C6	10604-108F1	1.85	17.88	1.23	1.85	0.00	0.00	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	2.12	13.32	0.61	0.91	0.00	0.30	0.30	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	1.23	14.82	2.16	1.85	0.00	0.62	0.00	0.31
embryonic pancreas cell line:2C6	10603-108E9	2.63	27.58	1.31	2.63	0.00	2.63	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	26.82	25.47	9.05	10.73	0.34	0.67	0.34	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	6.52	0.36	6.52	2.72	0.72	0.00	0.00	0.00
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	5.63	1.61	2.73	1.77	0.16	0.00	0.32	0.00
epidermoid carcinoma cell line:A431	10426-106D3	10.12	7.67	6.34	3.45	0.22	0.11	0.22	0.00
epidermoid carcinoma cell line:Ca Ski	10431-106D8	15.73	0.44	9.24	5.28	0.33	0.00	0.22	0.00
epididymis, adult	10197-103E8	7.95	31.82	1.88	1.67	0.21	1.26	1.67	0.42
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	3.73	0.18	5.50	3.02	0.71	0.00	0.00	0.00
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	0.79	0.39	2.36	0.39	0.39	0.00	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	29.75	0.39	11.66	7.60	1.70	0.00	0.66	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	26.57	0.39	12.30	6.99	0.98	0.00	0.59	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	31.48	0.11	13.44	7.06	1.23	0.00	0.56	0.00
esophagus, adult, pool1	10015-101C6	8.39	36.42	4.46	1.38	0.32	0.64	0.53	0.32
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	1.50	0.63	1.38	1.50	0.25	0.00	0.25	0.00
eye - muscle inferior rectus, donor1	10272-104E2	0.00	41.05	0.00	0.00	0.00	2.41	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	6.31	29.46	4.21	2.10	0.00	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	4.46	29.76	2.98	2.98	0.00	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	22.93	33.25	3.44	8.03	0.00	1.15	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	17.49	23.32	1.46	10.20	0.00	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	5.34	22.88	2.03	1.78	0.25	1.02	0.51	0.25
fibrosarcoma cell line:HT-1080	10758-110E2	6.80	0.77	4.62	4.62	0.26	0.00	0.00	0.00
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	27.30	2.61	12.35	14.48	1.19	0.00	0.24	0.47
frontal lobe, adult, pool1	10040-101F4	22.05	23.17	8.54	4.60	1.60	0.84	0.00	0.28
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	50.14	9.91	14.71	7.21	0.30	0.30	0.90	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	18.65	2.10	5.94	4.85	0.82	0.18	0.09	0.00
gall bladder, adult	10198-103E9	20.52	45.39	7.24	4.10	0.24	1.45	0.48	0.97
gamma delta positive T cells, donor1	11937-126A2	56.37	650.13	10.74	5.91	1.61	13.96	0.54	5.37
gamma delta positive T cells, donor2	11938-126A3	111.30	510.19	14.57	8.22	0.75	11.20	1.87	6.72
gastric adenocarcinoma cell line:MKN1	10614-108G2	8.24	18.80	4.22	0.84	1.06	0.63	1.27	0.21
gastric adenocarcinoma cell line:MKN45	10612-108F9	2.90	5.42	5.42	3.09	0.39	0.19	0.00	0.00
gastric cancer cell line:AZ521	10549-107H9	6.89	2.13	3.12	7.21	0.33	0.16	0.16	0.16
gastric cancer cell line:GSS	10560-108A2	5.49	12.81	0.92	6.41	0.00	0.00	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	9.14	5.03	2.06	1.37	0.00	0.69	0.69	0.46
giant cell carcinoma cell line:LU65	10487-107B1	0.57	0.69	1.49	0.92	0.00	0.00	0.00	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	14.00	9.24	7.98	6.02	0.84	0.42	0.00	0.00
glassy cell carcinoma cell line:HOKUG	10688-109F4	17.46	3.49	6.73	4.24	0.25	0.00	0.00	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	19.21	0.42	5.49	3.59	0.11	0.11	0.00	0.00
glioblastoma cell line:A172, tech_rep2	10444-106F3	21.91	0.56	7.30	4.07	0.14	0.00	0.14	0.00
glioblastoma cell line:T98G	10485-107A8	57.17	3.09	12.80	8.39	0.55	0.00	0.11	0.00
glioma cell line:GI-1	10413-106B8	8.20	1.17	4.10	2.34	0.29	0.00	0.00	0.00
globus pallidus - adult, donor10196	10175-103C4	11.66	15.31	5.83	6.56	0.00	0.00	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	16.35	25.14	10.98	6.10	0.49	0.49	0.49	0.24
globus pallidus, adult, donor10258	10367-105F7	2.74	26.01	8.22	5.48	0.00	1.37	0.00	1.37
globus pallidus, newborn, donor10223	10364-105F4	9.59	6.40	2.13	5.33	0.53	0.00	0.00	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	90.54	46.50	17.13	4.89	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	43.71	10.93	10.93	21.86	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	41.81	31.36	15.68	5.23	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	6.08	0.96	3.20	1.92	0.32	0.00	0.32	0.00
hIPS +CCl2, biol_rep1	14383-156B9	5.97	0.46	4.59	18.36	0.46	0.00	0.00	0.00
hIPS +CCl2, biol_rep2	14384-156C1	6.40	0.91	2.74	14.63	0.46	0.00	0.00	0.00
hIPS +CCl2, biol_rep3	14385-156C2	9.02	0.00	5.80	19.32	0.64	0.00	0.64	0.00
hIPS, biol_rep1	14380-156B6	5.75	2.87	4.31	15.81	1.44	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	10.29	0.00	4.80	26.06	0.69	0.69	0.00	0.00
hIPS, biol_rep3	14382-156B8	6.62	8.83	2.21	3.31	2.21	1.10	1.10	0.00
hairy cell leukemia cell line:Mo	10712-109I1	17.82	4.02	8.33	10.92	0.00	0.00	0.00	0.00
heart - mitral valve, adult	10205-103F7	15.85	27.80	6.58	2.39	0.30	1.20	0.30	0.60
heart - pulmonic valve, adult	10206-103F8	14.90	27.45	7.32	1.05	0.26	0.26	0.00	0.26
heart - tricuspid valve, adult	10207-103F9	17.49	19.98	8.33	9.99	0.00	0.00	0.83	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	10.41	19.59	7.96	3.06	0.61	0.61	0.20	0.00
heart, adult, diseased, donor1	10051-101G6	17.03	42.58	10.22	2.98	0.00	0.00	0.00	0.43
heart, adult, pool1	10016-101C7	22.08	29.44	9.20	4.60	0.69	0.46	0.23	0.00
heart, fetal, pool1	10046-101G1	16.02	32.45	4.83	2.98	0.10	0.72	0.00	0.21
hepatic mesenchymal tumor cell line:LI90	10778-110G4	11.42	0.93	4.63	3.39	0.00	0.00	0.00	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	1.19	1.19	0.00	0.00	0.00	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	6.52	1.44	3.31	2.32	0.55	0.11	0.11	0.11
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	10.68	1.34	3.16	3.64	0.49	0.00	0.36	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	7.07	0.91	1.92	3.44	0.20	0.00	0.10	0.00
hepatoma cell line:Li-7	10484-107A7	6.34	2.00	1.89	1.67	0.11	0.11	0.11	0.00
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	14.67	4.42	7.84	7.24	0.50	0.00	0.20	0.10
hippocampus - adult, donor10196	10169-103B7	13.25	11.36	7.57	6.62	2.84	0.95	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	13.27	40.82	6.74	4.90	0.00	0.41	0.20	0.41
hippocampus, adult, donor10258	10374-105G5	12.95	14.94	4.98	6.47	1.49	0.50	0.00	1.00
hippocampus, newborn, donor10223	10363-105F3	15.51	2.11	1.41	5.64	0.70	0.35	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	1.83	0.00	1.22	6.10	0.00	0.61	0.61	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	1.37	0.20	1.77	15.32	0.00	0.00	0.20	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	1.02	0.76	0.76	12.95	0.00	0.25	0.25	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	1.69	1.69	1.13	4.51	0.00	0.56	0.56	0.56
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	3.36	1.29	1.29	6.97	0.26	0.00	0.26	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	1.90	1.52	1.90	6.83	0.00	0.00	0.38	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	2.34	0.88	0.58	3.21	0.00	0.00	1.17	0.29
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	3.23	1.72	2.15	5.39	0.00	0.00	0.65	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	3.34	0.83	2.50	5.84	0.00	0.00	0.42	0.83
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	6.63	0.95	2.37	2.37	0.24	0.00	0.24	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	9.16	0.64	1.77	4.18	0.16	0.16	0.64	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	4.04	0.00	2.02	6.06	0.67	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	1.25	0.16	2.19	11.58	0.16	0.00	0.31	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	0.49	0.49	1.97	9.33	0.49	0.00	0.49	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	0.00	0.00	1.75	3.49	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	4.01	2.67	3.25	7.64	0.00	0.19	0.57	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	4.36	2.18	3.92	9.16	0.00	0.44	0.44	0.44
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	2.00	3.50	1.00	6.50	0.50	0.50	0.50	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	2.07	1.70	0.94	4.52	0.00	0.00	0.19	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	2.27	0.45	2.73	4.09	0.00	0.00	0.45	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	0.31	1.25	0.94	4.39	0.31	0.94	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	3.92	0.98	2.61	3.92	0.16	0.49	0.49	0.16
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	4.94	1.16	2.32	3.19	0.00	0.58	1.16	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	2.39	1.20	2.39	5.38	0.00	0.00	0.30	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	2.96	0.37	1.11	15.70	0.00	0.18	0.92	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	1.43	1.43	1.71	16.26	0.00	0.29	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	2.45	1.22	1.63	9.80	0.00	0.41	0.41	0.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	3.52	2.11	2.46	4.93	0.35	0.70	0.35	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	5.70	0.63	1.58	7.60	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	3.33	1.82	1.21	6.05	0.00	0.00	0.30	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	3.62	1.03	3.10	2.59	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	3.32	0.66	0.66	5.98	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	3.59	0.51	0.77	2.82	0.00	0.26	0.51	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	7.16	1.28	3.32	3.07	0.26	0.00	0.77	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	7.57	2.27	5.30	2.27	0.76	0.00	0.76	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	5.04	0.34	2.35	5.04	0.34	0.00	0.34	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	2.90	0.48	2.17	13.77	0.24	0.00	0.24	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	3.12	0.45	0.89	12.92	0.00	0.45	0.89	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	4.39	0.00	2.93	14.63	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	3.67	1.83	2.75	5.20	0.31	0.31	0.31	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	0.00	6.51	0.00	3.25	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	1.99	2.32	1.99	2.98	0.00	0.33	0.66	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	4.93	1.64	1.09	4.38	0.00	0.00	1.09	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	3.62	2.90	1.09	4.70	0.00	0.36	0.72	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	1.78	2.14	1.78	6.05	0.00	0.36	0.71	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	5.97	1.19	2.39	1.19	0.00	0.00	3.58	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	6.23	0.95	3.25	4.60	0.14	0.00	0.54	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	5.93	0.27	1.62	5.12	0.00	0.00	0.27	0.00
immature langerhans cells, donor1	11904-125F5	9.44	5.09	2.42	0.73	0.73	0.00	0.00	0.00
immature langerhans cells, donor2	11905-125F6	20.60	18.22	7.13	3.17	0.00	0.00	0.79	0.00
insula, adult, pool1	10039-101F3	30.38	23.47	12.30	5.96	1.61	1.32	0.00	0.66
keratoacanthoma cell line:HKA-1	10791-110H8	2.93	3.58	5.20	2.60	0.00	0.00	0.00	0.00
kidney, adult, pool1	10017-101C8	10.91	37.35	4.71	2.60	0.30	0.90	0.20	0.30
kidney, fetal, pool1	10045-101F9	11.74	27.23	3.25	1.70	0.14	1.13	0.07	0.64
large cell lung carcinoma cell line:IA-LM	10509-107D5	4.97	46.01	3.55	3.83	0.57	3.12	0.14	3.41
large cell lung carcinoma cell line:NCI-H460	10839-111E2	2.76	0.00	2.35	1.38	0.28	0.00	0.28	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	6.24	3.30	4.40	1.83	0.18	0.00	0.00	0.00
left atrium, adult, donor1	10079-102A7	7.63	7.63	7.08	4.36	0.54	0.00	0.54	0.00
left ventricle, adult, donor1	10078-102A6	8.60	16.18	4.55	3.03	0.51	0.00	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	3.28	0.00	3.28	3.28	0.27	0.00	0.00	0.00
leiomyoma cell line:10964C	10569-108B2	14.01	1.44	5.39	3.59	1.80	0.00	0.72	0.36
leiomyoma cell line:15242A	10570-108B3	29.89	1.09	8.15	9.24	0.54	0.00	0.00	0.00
leiomyoma cell line:15425	10571-108B4	21.85	0.00	8.26	5.83	1.70	0.00	1.21	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	6.35	0.00	6.35	6.35	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	12.55	7.32	7.32	2.09	0.00	0.00	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	130.45	87.60	37.19	50.65	1.65	1.06	1.06	0.94
liposarcoma cell line:KMLS-1	10782-110G8	15.46	0.16	9.22	5.47	0.16	0.00	0.31	0.00
liposarcoma cell line:SW 872	10726-110A6	23.15	11.21	9.14	4.26	0.73	0.12	0.12	0.37
liver, adult, pool1	10018-101C9	10.21	10.86	3.57	1.46	0.00	0.00	0.49	0.00
liver, fetal, pool1	10086-102B5	15.99	7.53	7.53	14.11	0.00	0.00	0.94	0.00
locus coeruleus - adult, donor10196	10182-103D2	13.12	6.27	4.37	5.25	0.44	0.00	0.15	0.29
locus coeruleus, adult, donor10252	10165-103B3	13.84	21.04	8.49	4.61	0.37	0.37	0.18	0.18
locus coeruleus, adult, donor10258	10375-105G6	16.93	12.41	7.34	9.31	0.00	0.56	0.56	0.56
locus coeruleus, newborn, donor10223	10362-105F2	2.94	6.31	1.68	2.10	0.00	0.00	1.26	0.42
lung adenocarcinoma cell line:A549	10499-107C4	37.50	3.46	13.70	10.24	0.83	0.00	0.28	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	26.89	11.03	8.96	4.83	0.69	0.00	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	5.54	9.89	2.50	2.64	1.05	0.13	0.00	0.26
lung, adult, pool1	10019-101D1	29.77	97.93	10.28	5.32	0.24	4.61	0.71	2.48
lung, fetal, donor1	10068-101I5	13.41	104.74	2.00	0.86	0.00	7.99	0.57	8.56
lung, right lower lobe, adult, donor1	10075-102A3	33.91	97.60	9.16	7.33	0.46	5.04	4.58	5.50
lymph node, adult, donor1	10077-102A5	20.35	240.94	5.21	2.84	0.00	2.84	3.31	2.84
lymphangiectasia cell line:DS-1	10727-110A7	6.36	1.53	3.51	1.53	0.00	0.00	0.44	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	59.47	13.89	16.00	12.83	0.91	0.00	0.45	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	6.80	16.99	5.10	0.00	0.00	0.00	0.00	0.00
mature adipocyte, donor1	12231-129F8	8.44	7.99	7.99	2.66	0.44	0.00	0.44	0.00
mature adipocyte, donor2	12232-129F9	9.96	11.21	3.94	0.83	0.00	0.00	0.21	0.00
mature adipocyte, donor3	12233-129G1	10.43	7.59	4.74	2.37	0.24	0.00	0.24	0.24
mature adipocyte, donor4	12234-129G2	5.79	8.42	3.95	0.53	0.00	1.05	0.00	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	13.34	5.48	6.67	9.77	0.24	0.24	0.24	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	16.92	19.18	7.90	5.64	2.26	1.13	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	14.34	42.48	6.07	4.78	1.29	0.37	0.37	0.18
medial frontal gyrus, adult, donor10258	10368-105F8	10.17	21.92	4.13	4.45	0.95	0.32	0.32	0.95
medial frontal gyrus, newborn, donor10223	10352-105E1	3.84	3.84	0.85	0.43	0.85	0.43	0.43	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	19.24	17.38	7.76	7.43	1.52	0.84	0.51	1.01
medial temporal gyrus, adult, donor10252	10156-103A3	13.79	31.41	7.64	3.82	1.70	0.42	0.42	0.42
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	3.85	23.12	1.93	3.85	5.78	0.00	1.93	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	14.35	14.35	0.00	14.35	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	12.92	4.67	3.59	2.87	0.72	0.36	0.00	0.72
medulla oblongata - adult, donor10196	10174-103C3	7.14	15.58	5.19	3.24	0.00	0.00	0.00	0.00
medulla oblongata, adult, donor10252	10155-103A2	11.15	31.27	7.12	5.42	0.31	0.46	0.00	0.31
medulla oblongata, adult, pool1	10038-101F2	19.26	27.83	6.78	3.51	0.49	0.90	0.08	0.57
medulla oblongata, newborn, donor10223	10361-105F1	10.07	13.19	3.47	4.86	1.04	0.35	0.69	0.35
medulloblastoma cell line:D283 Med	10838-111E1	16.16	1.33	5.31	9.96	0.00	0.00	0.44	0.22
medulloblastoma cell line:ONS-76	10759-110E3	11.74	0.98	6.36	8.56	0.12	0.00	0.00	0.12
melanoma cell line:COLO 679	10514-107E1	8.34	2.44	2.73	2.16	0.43	0.00	0.29	0.00
melanoma cell line:G-361	10465-106H6	3.53	5.16	1.63	2.17	0.00	0.00	0.27	0.00
meningioma cell line:HKBMM	10691-109F7	6.15	33.47	3.44	1.99	0.00	0.90	0.90	0.90
merkel cell carcinoma cell line:MKL-1	10843-111E6	60.80	0.00	9.69	3.52	0.00	0.00	0.00	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	19.96	4.67	8.04	3.37	0.00	0.26	0.52	0.26
mesenchymal precursor cell - adipose, donor1	11747-123G1	14.73	0.92	6.14	2.92	0.77	0.00	0.61	0.00
mesenchymal precursor cell - adipose, donor2	11748-123G2	4.18	0.73	2.36	0.91	0.73	0.00	0.00	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	9.52	1.66	0.41	4.56	0.83	0.00	0.41	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	7.30	1.55	3.09	1.12	0.70	0.00	0.00	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	7.51	2.50	1.35	2.31	0.96	0.19	0.00	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	11.80	6.94	2.78	0.69	0.00	0.00	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	3.78	0.34	2.23	2.06	1.20	0.00	0.00	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	6.44	2.19	3.45	1.96	0.58	0.00	0.12	0.00
mesenchymal precursor cell - cardiac, donor3	11754-123G8	13.13	1.19	5.57	6.63	0.80	0.00	0.40	0.00
mesenchymal precursor cell - cardiac, donor4	11755-123G9	21.34	1.22	5.54	5.27	0.81	0.00	0.27	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	20.91	1.00	7.11	6.26	1.14	0.00	0.43	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	2.63	4.94	1.98	0.99	1.65	0.33	0.33	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	10.93	2.21	5.95	3.87	0.69	0.00	0.14	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	27.93	2.09	14.31	9.08	2.09	0.00	0.70	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	7.35	1.63	4.49	3.27	0.61	0.00	0.20	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	11.50	6.11	2.52	2.52	2.52	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	3.93	0.62	2.69	1.97	0.52	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	12.31	5.24	4.79	2.96	2.28	0.00	1.14	0.23
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	13.01	1.68	2.52	3.78	0.42	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	14.20	1.64	5.53	3.29	0.60	0.15	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	11.82	2.01	5.25	5.08	0.35	0.00	0.26	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	5.52	4.42	0.74	1.47	0.74	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	14.31	3.72	3.72	2.29	2.29	0.00	0.57	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	42.10	5.89	9.26	7.16	0.42	0.00	1.26	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	9.13	0.91	3.65	6.39	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	4.86	0.26	4.86	2.05	0.00	0.26	0.26	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	9.42	1.57	4.45	6.02	0.00	0.00	0.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	11.09	0.62	2.46	3.70	0.62	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	7.53	0.71	1.88	3.53	0.24	0.00	0.47	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	6.43	1.35	2.37	3.38	0.34	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	7.47	2.36	3.54	2.75	0.79	0.00	0.39	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	7.88	1.85	0.46	1.85	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	8.36	1.73	2.88	3.17	0.29	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	6.25	2.01	4.46	3.57	0.45	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	8.17	0.72	4.09	4.57	0.24	0.00	0.48	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	5.13	1.47	5.13	3.67	0.73	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	3.02	0.00	2.01	2.35	0.34	0.00	0.67	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	6.55	0.41	2.87	2.87	1.64	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	3.44	3.87	3.01	3.01	1.29	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	13.67	2.73	0.00	0.00	2.73	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	5.16	5.16	5.16	5.16	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	5.20	1.30	2.92	2.60	0.32	0.00	0.32	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	8.73	2.91	2.91	2.91	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	9.06	0.53	3.20	7.46	0.53	0.00	0.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	4.91	4.91	5.72	3.27	0.82	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	5.05	3.11	3.89	2.72	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	4.20	2.10	6.30	4.20	2.10	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	2.98	1.99	0.00	0.99	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	0.00	4.77	4.77	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	5.34	5.34	3.56	1.78	1.78	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	19.50	10.97	1.22	2.44	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	8.23	7.60	3.80	1.90	0.63	0.00	0.63	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	3.10	10.35	2.76	1.72	0.34	0.00	0.69	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	0.00	6.45	2.15	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	7.98	11.98	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	3.44	6.89	3.44	3.44	3.44	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	2.85	6.52	5.30	2.04	0.41	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	2.38	9.53	3.18	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	5.90	9.43	4.13	2.95	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	6.23	9.35	0.94	0.94	0.62	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	2.67	6.68	2.67	1.34	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	18.92	15.37	8.28	8.28	1.18	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	7.70	5.14	2.57	2.57	2.57	0.00	2.57	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	13.77	13.77	6.20	6.20	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	48.49	2.47	12.86	8.91	0.49	0.00	0.49	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	54.95	2.24	12.34	11.22	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	40.07	1.91	15.27	7.63	1.27	0.00	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	49.97	0.00	15.31	11.28	0.81	0.00	1.61	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	43.61	0.00	8.72	17.44	2.18	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	40.55	0.00	11.40	7.60	0.00	0.00	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	12.74	0.00	9.10	7.89	1.21	0.00	0.61	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	18.08	0.00	9.04	13.56	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	12.36	0.00	9.88	4.94	0.82	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	18.45	2.58	6.75	3.37	0.60	0.00	0.40	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	15.90	4.22	7.46	5.19	0.00	0.00	1.30	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	21.39	5.09	7.13	1.02	0.00	0.00	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	10.06	3.87	6.19	3.09	0.77	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	15.59	12.76	10.16	7.32	0.47	0.00	0.00	0.24
mesothelioma cell line:ACC-MESO-4	10494-107B8	19.69	9.27	4.87	2.78	1.39	0.00	0.23	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	8.55	0.00	12.82	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	10.28	1.54	4.62	2.77	0.31	0.00	0.00	0.00
mesothelioma cell line:Mero-25	10850-111F4	14.75	1.82	5.45	5.67	0.91	0.23	0.23	0.00
mesothelioma cell line:Mero-41	10851-111F5	40.83	0.24	7.58	7.58	0.73	0.00	0.24	0.00
mesothelioma cell line:Mero-48a	10852-111F6	12.62	2.44	5.54	5.98	0.44	0.00	0.22	0.00
mesothelioma cell line:Mero-82	10853-111F7	10.25	18.40	4.47	3.15	0.00	0.00	0.00	0.53
mesothelioma cell line:Mero-83	10854-111F8	6.98	1.53	3.40	3.40	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-84	10855-111F9	48.53	0.76	10.62	14.91	1.01	0.25	1.77	0.00
mesothelioma cell line:Mero-95	10856-111G1	7.04	1.66	2.48	2.69	0.83	0.00	0.00	0.00
mesothelioma cell line:NCI-H2052	10847-111F1	20.37	0.17	5.80	6.63	0.83	0.00	0.00	0.00
mesothelioma cell line:NCI-H226	10846-111E9	21.00	0.18	5.61	5.07	1.27	0.00	0.36	0.00
mesothelioma cell line:NCI-H2452	10848-111F2	16.23	2.05	6.49	5.47	0.68	0.00	0.68	0.00
mesothelioma cell line:NCI-H28	10845-111E8	35.37	0.00	10.94	11.96	0.51	0.00	0.76	0.00
mesothelioma cell line:No36	10857-111G2	19.57	0.65	6.85	9.13	0.65	0.00	0.33	0.00
mesothelioma cell line:ONE58	10858-111G3	41.46	12.73	6.23	4.34	1.35	0.27	1.08	0.54
migratory langerhans cells, donor1	11901-125F2	1.15	1.92	0.58	0.58	0.00	0.00	0.00	0.00
migratory langerhans cells, donor2	11902-125F3	4.03	2.08	1.83	1.22	0.12	0.00	0.00	0.00
migratory langerhans cells, donor3	11903-125F4	2.15	1.08	1.62	0.90	0.00	0.00	0.00	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	36.24	2.29	15.02	9.47	0.65	0.00	1.31	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	17.59	0.64	10.81	9.75	0.85	0.00	0.42	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	8.52	0.92	7.60	2.07	0.00	0.00	0.00	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	23.03	9.70	7.61	5.33	0.38	0.00	0.38	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	177.95	10.53	40.84	19.96	0.37	0.00	2.03	0.00
myeloma cell line:PCM6	10474-106I6	3.56	0.00	2.37	1.19	0.59	0.00	0.20	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	7.10	0.51	3.55	2.54	1.01	0.00	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	10.98	0.00	6.28	1.57	0.59	0.00	0.00	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	0.78	2.12	1.23	0.89	0.22	0.00	0.00	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	0.81	2.28	0.59	0.51	0.15	0.00	0.07	0.07
nasal epithelial cells, donor2	12227-129F4	27.60	11.04	5.52	15.46	0.55	0.55	0.55	0.00
neuroblastoma cell line:CHP-134	10508-107D4	7.36	0.92	3.68	3.45	0.23	0.00	0.00	0.00
neuroblastoma cell line:NB-1	10539-107G8	18.33	0.37	6.55	8.98	0.00	0.00	0.00	0.00
neuroblastoma cell line:NBsusSR	10607-108F4	8.44	0.63	3.80	3.16	0.84	0.00	0.00	0.00
neuroblastoma cell line:NH-12	10555-107I6	6.89	6.34	2.05	4.10	0.37	0.19	0.00	0.19
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	1.42	18.98	0.71	0.71	0.00	2.14	0.00	0.24
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	5.54	6.02	2.85	1.43	0.16	0.79	0.16	0.00
neuroectodermal tumor cell line:TASK1	10774-110F9	6.64	1.21	3.62	4.03	0.00	0.00	0.20	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	15.89	3.18	8.26	3.18	1.27	0.00	0.64	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	6.39	0.27	4.26	2.93	0.27	0.00	0.00	0.00
neutrophil PMN, donor1	12133-128D9	1056.11	0.00	133.87	104.12	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	212.49	13.28	39.84	26.56	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	435.65	37.88	28.41	28.41	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	604.44	47.35	126.67	163.54	0.85	2.37	3.04	0.17
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	11.21	0.80	6.40	1.60	0.00	0.80	0.80	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	15.07	3.53	7.05	2.89	0.96	0.00	0.00	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	39.94	2.36	8.67	8.67	1.58	0.00	0.53	0.79
nucleus accumbens, adult, pool1	10037-101F1	31.87	19.40	10.31	6.75	1.12	1.03	0.19	0.56
occipital cortex - adult, donor10196	10172-103C1	14.42	24.72	4.12	2.06	6.18	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	15.57	45.35	6.98	6.17	0.27	0.81	0.27	1.07
occipital cortex, newborn, donor10223	10355-105E4	13.83	5.46	3.28	4.00	0.73	0.00	0.36	0.00
occipital lobe, adult, donor1	10076-102A4	22.30	27.55	9.97	7.87	1.31	0.52	1.05	0.26
occipital lobe, fetal, donor1	10073-102A1	10.30	7.72	7.72	6.87	0.43	0.43	0.43	0.00
occipital pole, adult, pool1	10036-101E9	27.28	28.46	11.35	4.89	2.21	2.05	0.16	1.18
olfactory region, adult	10195-103E6	20.82	33.05	6.30	4.97	0.96	0.76	0.76	0.76
optic nerve, donor1	10277-104E7	12.01	34.02	2.00	4.00	0.00	2.00	2.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	3.42	0.11	2.62	2.16	0.68	0.00	0.23	0.00
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	12.64	2.20	5.63	8.11	0.27	0.00	0.27	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	2.54	1.52	0.85	0.34	0.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	5.31	10.63	2.31	1.39	0.69	0.00	0.23	0.12
osteoclastoma cell line:Hs 706.T	10704-109H2	6.47	1.47	2.94	2.94	0.00	0.00	0.00	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	11.21	28.96	4.67	10.28	2.80	0.93	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	92.25	16.54	20.78	20.36	2.54	0.64	0.85	0.42
ovary, adult, pool1	10020-101D2	9.08	18.96	5.15	2.01	0.17	0.70	0.44	0.26
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	11.37	1.65	6.97	7.70	0.00	0.00	0.18	0.00
pancreas, adult, donor1	10049-101G4	7.53	27.28	1.88	1.88	0.00	0.00	0.00	2.82
pancreatic carcinoma cell line:NOR-P1	10698-109G5	36.06	1.96	11.46	7.83	0.56	0.28	0.00	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	8.86	0.68	2.73	1.53	0.34	0.00	0.68	0.00
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	14.07	8.11	7.45	2.48	0.17	0.00	0.17	0.00
paracentral gyrus, adult, pool1	10035-101E8	27.82	20.78	8.69	5.13	1.37	1.19	0.18	0.64
parietal cortex, adult, donor10258	10373-105G4	33.76	13.21	4.40	9.54	0.73	0.00	0.00	2.20
parietal lobe - adult, donor10196	10171-103B9	13.17	17.87	5.64	1.88	1.88	0.00	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	11.69	33.92	7.41	2.85	1.14	0.29	0.00	0.00
parietal lobe, adult, pool1	10034-101E7	24.14	26.88	11.28	5.73	2.11	1.41	0.00	0.18
parietal lobe, fetal, donor1	10072-101I9	5.82	2.91	1.94	4.85	0.00	0.97	0.00	0.00
parietal lobe, newborn, donor10223	10356-105E5	8.97	6.36	1.87	2.99	0.75	0.75	0.37	0.37
parotid gland, adult	10199-103F1	5.55	56.12	1.23	1.23	0.00	0.00	0.62	0.00
penis, adult	10200-103F2	6.45	33.30	4.30	1.61	0.54	1.61	0.00	2.15
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	2.05	7.62	1.12	0.37	0.00	0.19	0.00	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	16.75	5.25	8.60	4.81	0.58	0.00	0.29	0.44
pineal gland - adult, donor10196	10179-103C8	10.97	26.45	5.16	5.81	0.00	0.00	0.00	1.29
pineal gland, adult, donor10252	10160-103A7	18.95	24.28	9.48	4.15	0.00	0.59	0.59	0.59
pineal gland, adult, donor10258	10377-105G8	4.39	6.90	5.02	2.51	0.00	0.00	0.00	0.00
pituitary gland - adult, donor10196	10180-103C9	10.12	19.22	8.09	2.02	0.00	2.02	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	7.30	36.48	6.25	2.61	0.52	0.00	1.04	0.52
pituitary gland, adult, donor10258	10378-105G9	5.11	9.36	5.11	3.40	1.70	0.00	0.00	0.00
placenta, adult, pool1	10021-101D3	36.01	10.21	10.43	5.16	0.32	0.11	0.75	0.32
plasma cell leukemia cell line:ARH-77	10840-111E3	12.98	6.75	4.11	5.69	0.13	0.00	0.26	0.13
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	43.89	27.70	10.74	4.05	0.31	0.31	0.31	0.78
pons, adult, pool1	10033-101E6	16.87	14.03	5.16	3.61	0.86	0.26	0.00	0.43
postcentral gyrus, adult, pool1	10032-101E5	25.19	27.46	11.16	7.24	2.35	1.05	0.35	0.52
promyelocytes/myelocytes PMC, donor1	12132-128D8	25.10	6.27	16.73	2.09	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	27.54	0.00	5.51	5.51	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	23.47	11.74	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	10.05	2.18	4.37	2.48	0.73	0.00	0.29	0.00
prostate cancer cell line:PC-3	10439-106E7	17.24	11.25	5.26	3.81	0.54	0.36	0.18	0.18
prostate, adult, pool1	10022-101D4	10.52	37.73	3.08	1.72	0.18	1.36	0.27	0.36
putamen, adult, donor10196	10176-103C5	26.91	19.12	8.50	5.43	0.71	0.71	0.47	0.00
putamen, adult, donor10252	10152-102I8	13.73	17.65	11.76	0.00	1.96	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	12.02	1.09	5.46	5.46	4.37	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	20.54	10.39	5.32	4.35	2.66	0.00	0.00	0.48
putamen, newborn, donor10223	10365-105F5	6.00	3.75	0.75	0.75	0.00	0.00	0.00	0.75
rectal cancer cell line:TT1TKB	10469-106I1	7.86	3.78	5.24	1.16	0.00	0.00	0.00	0.00
rectum, fetal, donor1	10067-101I4	13.91	13.91	12.52	6.95	0.00	1.39	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	13.14	0.42	3.82	1.70	0.42	0.00	0.00	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	0.00	2.07	1.24	0.00	0.00	0.00	0.00	0.00
retina, adult, pool1	10030-101E3	11.33	34.59	4.67	2.78	0.40	1.29	0.10	0.50
retinoblastoma cell line:Y79	10475-106I7	32.22	1.04	14.81	10.13	0.52	0.00	0.26	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	5.66	0.74	3.07	4.30	0.25	0.00	0.00	0.00
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	196.84	12.94	74.24	78.74	0.28	0.00	0.84	0.28
sacrococcigeal teratoma cell line:HTST	10695-109G2	6.06	3.79	6.82	0.76	0.76	0.00	0.00	0.00
salivary acinar cells, donor1	11771-123I7	1.94	70.89	0.97	0.32	0.16	2.75	0.32	1.78
salivary acinar cells, donor2	11772-123I8	4.27	109.32	1.24	0.69	0.00	1.38	0.96	1.93
salivary acinar cells, donor3	11773-123I9	1.99	103.28	0.66	0.66	0.00	0.66	0.00	0.66
salivary gland, adult, pool1	10093-102C3	4.00	54.34	2.29	1.14	0.00	0.57	0.00	1.72
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	5.06	1.35	3.96	1.18	0.42	0.00	0.17	0.00
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	5.29	2.00	2.35	2.82	0.59	0.00	0.12	0.00
seminal vesicle, adult	10201-103F3	4.23	56.08	0.53	1.59	0.53	0.53	0.53	1.06
serous adenocarcinoma cell line:JHOS-2	10639-108I9	7.04	7.04	1.94	0.73	1.46	0.00	0.49	0.00
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	5.54	1.51	3.52	1.51	0.25	0.00	0.00	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	29.10	1.00	5.02	13.05	0.00	0.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	42.98	3.36	13.70	14.91	0.54	0.13	0.27	0.00
signet ring carcinoma cell line:Kato III	10436-106E4	24.87	0.55	13.71	4.64	0.55	0.00	0.44	0.00
signet ring carcinoma cell line:NUGC-4	10483-107A6	17.29	0.90	5.94	2.19	0.13	0.00	0.00	0.00
skeletal muscle - soleus muscle, donor1	10282-104F3	0.71	17.02	0.00	0.71	0.00	0.71	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	4.68	18.95	2.40	0.36	0.24	0.48	0.12	0.12
skeletal muscle, fetal, donor1	10066-101I3	27.14	8.04	6.03	5.03	0.00	0.00	2.01	0.00
skin, adult, donor1	10074-102A2	6.79	54.28	6.79	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	13.89	15.78	5.68	3.79	0.00	0.00	0.63	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	30.35	3.34	9.34	7.00	0.33	0.00	0.00	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	7.25	9.46	1.89	3.47	0.95	0.63	0.00	0.63
small cell lung carcinoma cell line:DMS 144	10841-111E4	13.88	2.12	15.23	15.03	0.77	0.19	0.77	0.19
small cell lung carcinoma cell line:LK-2	10541-107H1	7.58	3.46	3.13	2.64	0.16	0.00	0.16	0.00
small cell lung carcinoma cell line:NCI-H82	10842-111E5	5.15	2.41	5.31	9.81	0.16	0.16	0.48	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	27.46	21.57	11.99	6.54	0.22	1.53	0.22	1.74
small intestine, adult, pool1	10024-101D6	19.11	26.40	8.84	2.27	0.36	0.84	0.48	0.36
small intestine, fetal, donor1	10064-101I1	21.38	5.16	9.34	4.42	0.25	0.49	0.49	0.25
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	35.90	23.08	6.15	5.64	2.05	0.51	1.54	0.00
smooth muscle, adult, pool1	10048-101G3	6.20	23.00	2.33	1.29	0.00	0.52	0.00	0.00
somatostatinoma cell line:QGP-1	10781-110G7	4.02	4.82	4.02	4.29	0.00	0.00	0.00	0.27
spinal cord - adult, donor10196	10181-103D1	9.64	13.99	5.51	5.74	0.23	0.46	0.69	0.00
spinal cord, adult, donor10252	10159-103A6	8.67	28.78	4.34	4.34	0.79	0.00	0.00	0.39
spinal cord, adult, donor10258	10369-105F9	3.46	17.29	2.08	1.38	0.00	0.00	0.69	0.69
spinal cord, fetal, donor1	10056-101H2	15.86	9.15	7.93	6.71	0.00	0.00	0.00	0.61
spinal cord, newborn, donor10223	10359-105E8	6.89	13.32	2.76	2.76	0.00	0.00	0.46	0.46
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	14.79	0.00	9.71	6.27	0.75	0.00	0.00	0.00
spleen, adult, pool1	10025-101D7	54.08	110.91	9.91	7.16	1.10	1.10	1.43	0.66
spleen, fetal, pool1	10044-101F8	52.44	93.92	9.30	4.85	0.32	1.59	0.32	0.95
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	5.59	1.86	3.00	1.86	0.21	0.00	0.10	0.00
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	1.14	4.37	2.85	1.14	0.19	0.00	0.19	0.19
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	6.64	11.18	4.54	4.19	0.35	0.35	0.00	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	3.52	3.13	0.78	2.74	0.39	0.00	0.00	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	4.73	3.04	4.39	1.69	0.68	0.00	0.00	0.00
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	72.01	1.27	13.13	20.76	0.85	0.00	0.85	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	8.88	5.50	3.81	2.96	1.69	0.00	0.00	0.00
stomach, fetal, donor1	10062-101H8	3.20	68.35	1.07	2.14	0.00	2.14	0.00	2.14
submaxillary gland, adult	10202-103F4	6.84	62.66	0.57	1.71	0.00	2.85	1.14	0.57
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	13.09	27.42	9.55	3.12	0.42	0.00	0.42	0.42
substantia nigra, adult, donor10258	10371-105G2	9.31	10.35	3.10	5.17	1.03	0.52	0.00	0.52
substantia nigra, newborn, donor10223	10358-105E7	7.77	11.31	1.41	4.24	0.00	0.71	0.71	0.71
synovial sarcoma cell line:HS-SY-II	10441-106E9	19.72	5.27	10.09	6.88	1.15	0.00	0.46	0.46
temporal lobe, adult, pool1	10031-101E4	30.86	30.43	12.12	6.87	2.20	1.19	0.25	0.85
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	7.83	3.56	4.99	3.56	0.00	0.00	0.00	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	18.02	3.96	3.96	5.27	0.44	0.00	0.44	0.00
tenocyte, donor1	11763-123H8	19.55	3.49	9.08	5.93	1.40	0.00	1.05	0.00
tenocyte, donor2	11765-123I1	8.01	3.82	6.10	4.20	1.53	0.00	0.00	0.00
tenocyte, donor3	11768-123I4	17.42	2.59	7.78	7.04	1.11	0.00	0.74	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	5.44	0.51	4.25	17.00	0.17	0.00	0.34	0.00
teratocarcinoma cell line:NCR-G1	10798-110I6	18.81	1.08	7.86	8.02	0.15	0.00	0.31	0.00
teratocarcinoma cell line:PA-1	10807-111A6	3.25	0.31	3.56	15.03	0.15	0.00	0.15	0.00
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	24.25	1.02	14.85	46.08	0.76	0.00	0.63	0.00
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	12.86	0.00	10.59	48.03	1.13	0.00	0.00	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	30.54	2.07	8.83	25.74	0.44	0.00	0.65	0.11
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	2.93	0.33	2.28	15.96	0.00	0.00	0.00	0.00
testis, adult, pool1	10026-101D8	6.76	37.69	2.79	2.68	0.11	0.54	0.75	0.64
testis, adult, pool2	10096-102C6	9.02	9.47	3.16	4.06	0.45	0.00	0.00	0.45
thalamus - adult, donor10196	10168-103B6	9.94	9.94	7.73	9.94	1.10	0.00	2.21	1.10
thalamus, adult, donor10252	10154-103A1	12.19	30.79	7.19	5.47	0.31	0.47	0.16	0.16
thalamus, adult, donor10258, tech_rep1	10370-105G1	12.32	7.70	1.54	4.62	0.00	0.00	0.00	3.08
thalamus, adult, donor10258, tech_rep2	10370-105G1	8.23	10.87	4.78	4.45	1.15	0.16	0.33	0.66
thalamus, newborn, donor10223	10366-105F6	2.30	1.73	2.30	0.58	1.15	0.00	0.00	0.00
throat, adult	10209-103G2	12.73	41.45	6.99	2.75	0.25	0.75	0.50	0.75
throat, fetal, donor1	10061-101H7	10.66	21.63	3.66	3.96	0.91	1.22	0.30	0.91
thymic carcinoma cell line:Ty-82	10803-111A2	32.39	1.39	9.54	8.15	0.00	0.00	0.60	0.00
thymus, adult, pool1	10027-101D9	304.61	245.16	38.97	29.73	0.89	10.94	5.96	6.26
thymus, fetal, pool1	10043-101F7	106.81	305.69	17.87	12.36	0.10	14.86	1.14	7.69
thyroid carcinoma cell line:KHM-5M	10776-110G2	37.10	2.79	8.51	7.05	1.33	0.27	0.80	0.00
thyroid carcinoma cell line:TCO-1	10783-110G9	8.38	4.75	5.73	4.47	0.56	0.00	0.00	0.00
thyroid, adult, pool1	10028-101E1	8.30	104.60	3.27	1.68	0.00	7.47	0.65	2.99
thyroid, fetal, donor1	10060-101H6	5.80	15.56	3.43	4.75	0.00	0.26	0.00	0.26
tongue epidermis (fungiform papillae), donor1	10288-104F9	3.08	110.87	0.00	3.08	0.00	6.16	0.00	3.08
tongue, adult	10203-103F5	11.16	17.68	3.26	2.09	0.47	0.47	0.00	0.00
tongue, fetal, donor1	10059-101H5	5.52	5.91	9.06	3.55	0.39	0.00	1.97	0.79
tonsil, adult, pool1	10047-101G2	23.94	118.91	8.82	3.81	0.30	2.20	0.30	1.20
trachea, adult, pool1	10029-101E2	17.67	58.81	6.22	1.72	0.49	1.06	0.57	1.15
trachea, fetal, donor1	10058-101H4	8.08	28.08	1.15	1.92	0.00	0.77	0.00	0.77
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	26.57	1.06	11.69	11.69	0.35	0.71	0.71	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	13.58	0.51	3.14	2.43	0.00	0.00	0.00	0.00
transitional-cell carcinoma cell line:JMSU1	10492-107B6	4.70	5.01	2.98	1.57	0.00	0.16	0.31	0.00
tridermal teratoma cell line:HGRT	10694-109G1	9.51	3.81	3.81	3.81	0.00	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	10.75	11.94	5.33	6.01	0.17	0.17	0.17	0.17
umbilical cord, fetal, donor1	10057-101H3	14.61	18.78	10.43	2.09	2.09	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	6.31	40.61	1.71	0.51	0.17	0.17	0.34	0.51
uterus, fetal, donor1	10055-101H1	8.70	22.01	6.14	4.10	0.00	0.51	0.00	0.00
vagina, adult	10204-103F6	12.92	39.42	5.82	2.58	0.00	0.00	0.00	1.29
vein, adult	10191-103E2	35.29	163.52	6.36	4.16	0.44	5.04	2.85	2.41
xeroderma pigentosum b cell line:XPL 17	10563-108A5	12.28	5.87	7.21	4.54	0.00	0.00	0.00	0.00